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1. INTRODUCTION 
1.1 Tubular organs - an overview 
 
Tubular structures are a recurring anatomic feature in all multicellular life forms. The 
branched and hierarchal nature of tubes is common among several organs in the vertebrates. 
Among higher vertebrates, organs with tubular composition include the vascular, pulmonary, 
digestive and excretory systems, as well as the secretory organs such as the mammary, 
pancreatic and salivary glands. The Drosophila melanogaster tracheal system, the equivalent 
of the vertebrate lung is a prototypical model for studying molecular mechanisms governing 
tubular network development owing to the relatively simple structure of the respiratory 
system.  
 
1.2 Tracheal morphogenesis in Drosophila 
 
Tracheal branches are monolayer epithelial cells wrapped into tubes surrounding a central 
lumen through which gases flow (CASANOVA 2007). The tracheal system is bilaterally 
symmetric and segmentally repeated in its organisation, which reflects its developmental 
origin. The tracheal system comprises of three kinds of branches; the primary, secondary and 
the tertiary (terminal) branches, each established according to the sequence of migration and 
tube formation. During embryonic development (5hr After Egg Lay), 10 bilaterally 
symmetrical ectodermal cell clusters consisting of ~ 80 cells invaginate into an epithelial sac 
called the tracheal placode. The tracheal placode develops into interconnected tubes through 
a series of events including cell migration, intercalation and fusion (Fig.1). Over the course of 
the next few hours, six primary tracheal branches migrate out from each tracheal placode at 
stage 12 (Fig.1b, e). The branches bud out with a pair of leading cells followed by a small 
number of cells that organise into a tube during the migration process. At stage 15, the 
primary branches are ensued by the two-dozen secondary branches (Fig.1d, e). During further 
stages of development, the secondary branches sprout terminal branches. Much of the 
development of terminal cells takes place during larval phases in response to physiological 
oxygen demands. 
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Figure 1: Stages of embryonic tracheal development in Drosophila melanogaster 
The Drosophila tracheal system develops by sequential branching from a tracheal sac in each hemisegment. (a–
d) Embryonic tracheal development visualised by immunostaining of the tracheal lumen. Embryo stage and age 
(in hours) are indicated. The first (Tr1) and the tenth (Tr10) tracheal hemisegments are indicated in (a). Brackets 
indicate position of fifth tracheal hemisegment (Tr5). Lateral views, anterior left, dorsal up. (e) Development of 
Tr5. The spiracular branch (SB), transverse connective (TC) and the six primary branches (DB, dorsal branch; 
DTa and DTp, anterior and posterior dorsal trunk; VB, visceral branch; LTa, anterior lateral trunk; LTp/GB, 
posterior lateral trunk/ganglionic branch) are indicated. Primary branches at stage 12 and secondary branches at 
stage 15 are highlighted green. Most secondary branches ramify to form terminal branches in the larval period 
(not shown). The branches that cease branching and fuse with branches in neighbouring hemisegments are 
indicated (arrowheads).Adapted from (GHABRIAL et al. 2003). 
 
Branching morphogenesis of the trachea involves the Fibroblast Growth Factor (FGF) 
signalling pathway that is used repeatedly to control branch budding and outgrowth 
(GHABRIAL et al. 2003; METZGER 1999; SATO 2002; SKAER 1997). branchless (bnl) 
(SUTHERLAND et al. 1996), and breathless (btl) (KLÄMBT et al. 1992) encode the Drosophila  
homologues of the mammalian FGF and the FGF receptor and are critical for the induction 
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and maintenance of the tracheal system (Fig.2a). Although the Bnl/Btl signalling provides the 
cues for development, a different tubulogenesis mechanism is used at each level of branching 
concurrent with stages of development (Fig.2b). 
 
 
Figure 2: The Branchless FGF pathway controls each step of branching. 
(a) branchless/ FGF (blue) is expressed in clusters of cells surrounding the developing tracheal system, at each 
position where a primary branch will bud. The secreted growth factor activates the Breathless FGFR on nearby 
tracheal cells (black), and acts as a chemoattractant that guides outgrowth of primary branches. It also induces 
expression of secondary branch genes and triggers secondary branch sprouting at the ends of outgrowing 
primary branches (green; stages 12–16). branchless turns back on again, but in a completely different pattern, 
during larval life to control outgrowth of terminal branches. The gene is expressed yet again during pupal life 
where it controls budding of adult air sacs (not shown). (b) The genes that function upstream of Branchless and 
downstream of Breathless change during development, giving rise to different patterns and structures of 
branches at each step. Adapted from (GHABRIAL et al. 2003)  
 
 
 
Further, different branches within each metamere have a fixed number of cells (SAMAKOVLIS 
et al. 1996) with each branch featuring characteristic tube dimensions (BEITEL and KRASNOW 
2000). Primary branches are composed of multicellular tubes with two to five wedge-shaped 
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cells surrounding a lumen and interconnected by intracellular junctions (Fig.3a). In secondary 
branches, tubes are made up of interconnected cells lying in a single row that form a tube by 
folding over itself along the long axis and sealing via an autocellular junction (Fig.3b). 
However, unlike primary and secondary branches terminal cells form a junctionless and 
therefore “seamless” lumen (Fig.3c). Also present within the tracheal system are pairs of 
doughnut-shaped cells (fusion cells) that are derived from primary branches. Two fusion cells 
extending from the primary branches of each metamere connect to form a fusion anastomosis 
to give rise to a continuous network. The tube formed by fusion cells is as a result seamless 
and without intracellular junction (Fig.4). The developmental design of the primary and 
secondary branch formation is highly stereotyped and pre-programmed unlike branch 
formation in terminal cells, where branching is highly variable and regulated by oxygen 
demand.  
 
 
 
 
Figure 3: Types of simple epithelial tubes that constitute the Drosophila tracheal system 
Tube walls are formed by polarised epithelial cells with their apical membrane surface (red) facing inward 
toward the lumen space and their basal surface (green) exposed to the extracellular matrix. (a) A multicellular 
tube with four curved cells in a cross-sectionof the tube; (b) A unicellular tube formed by a single cell, rolled up 
to enclose the lumen, and sealed with an autocellular junction; (c) A unicellular tube with the lumen in the 
cytoplasm of the cell. There is no autocellular junction; the tube is “seamless.”Adapted from (LUBARSKY and 
KRASNOW 2003). 
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Figure 4: Schematic representation of fusion anastomosis  
Fusion branches (anastomoses) connect the individual metameres and are made by two cells that, before fusion, 
are positioned at the tips of the two branches that will fuse. Each fusion cell is doughnut shaped with no 
autocellular junctions and forms intercellular junctions with its fusion partner and with the following cell in the 
primary branch Adapted from (UV et al. 2003). 
 
1.3 Terminal cell and branch development 
 
Cells that do not participate in the formation of secondary branches are specified to become 
terminal cells. Though the specification to become terminal cells occurs in embryonic stages 
much of the development takes place during larval phases. Terminal cells are outposts of the 
tracheal system responsible for oxygen delivery to target tissues. Terminal branches originate 
as cytoplasmic protrusions that develop a lumen intracellularly (Fig.5). Branching 
morphogenesis in terminal cells is a reiterative process that occurs during the five days of 
larval development, involving rounds of cytoplasmic extension, followed by lumen formation 
to create a ramified network that contacts cells of the target tissue (KEISTER 1948). Oxygen 
carried through the terminal branches is made available at target tissues through diffusion that 
is facilitated by the close contact between the plasma membrane of the tissue and the blind-
end of the terminal branch (MANNING 1993).  
 
The terminal branches consist of a lumen whose diameter, decreases progressively along with 
the branch diameter with increasing distance from the nucleus. The average lumen diameter 
of a terminal is less than 1 µm (GUILLEMIN et al. 1996; LUBARSKY and KRASNOW 2003; 
WIGGLESWORTH 1954). Terminal cells also show apical-basal polarity, with the outer 
membrane being the basal membrane, and the membrane facing the lumen being apical which 
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shows enrichment of the apical polarity complex Par6/aPKC/Baz along with Crumbs (Jayan 
N. Nair, PhD thesis) (GERVAIS and CASANOVA 2010). Terminal cells on an average have 20 
branches and the branching points are regularly spaced and do not cross over one another. 
The terminal cell arborisation may span distances over 100 µm. Unlike earlier stages of 
tracheal branching, terminal cell branching is not stereotyped but governed by oxygen 
physiology in tissues, resulting in terminal cells with varied branching patterns.  
 
 
Figure 5: A terminal cells from a third instar larval trachea 
The terminal cell is visualised by trachea specific expression of cytoplasmic GFP using btlGal4. The terminal 
cell extends long processes toward target tissues, called the terminal branches. Each terminal branch bears a 
lumen within through which air is transported to be supplied to tissues. The terminal cell nucleus is marked with 
a star (Jayan N. Nair PhD thesis). 
 
The process of lumen formation within the terminal branches is not quite well understood. 
Early work in Drosophila showed the presence of cytoplasmic vesicles in the terminal 
branches distal from the nucleus (Fig.6a) (SHAFIQ 1963). It is believed that these vesicles fuse 
to form a larger vesicular body that would coalesce with the already existing tracheal lumen. 
This is supported by the presence of Crumbs-positive vesicles at the distal regions of terminal 
branches that did not yet possess a lumen (Fig.6b) (Jayan N. Nair PhD thesis). Moreover, 
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these Crumbs-positive vesicles appear to line up parallel to each other as if forming a lumen. 
Further, work on angiogenesis using cell lines have shown that vacuoles are generated prior 
to lumen formation and a lumen is formed when these vesicles fuse together (FOLKMAN and 
HAUDENSCHILD 1980). 
 
Figure 6: Growing ends of the tracheoles show multi-vesicular structures  
(a) Electron micrograph of the tip of a developing tracheal branch. Arrows mark vesicular structures within the 
distil region of the tracheoles. (b) Crumbs-GFP localisation in vesicles at distal regions of a terminal branch 
where the lumen is beginning to develop. The branch is marked with DsRed expressed using btlGal4. The red 
and green arrows mark the proximal (to the nucleus) and distal ends of the branch, respectively. Adapted from 
(a) (SHAFIQ 1963) and (b) Jayan N. Nair (PhD thesis). 
 
 However, contrary to the idea of de novo tube formation through vesicular fusion, lumen 
formation has also been described to occur in a proximal to distal manner. Work in 
embryonic tracheal system showed that lumen in terminal cells formed by the growth of a 
new membrane into the cell from the surface contacting the adjacent cell. The membrane 
formed was the apical membrane as seen from the accretion of apical polarity complexes, 
aPKC/Par6/Baz and Crb/DPatj complexes (GERVAIS and CASANOVA 2010).  Perhaps lumen 
Introduction  
12 
 
formation is a combination of both mechanisms, where lumen formation in early stages of 
tracheal development is predominantly from extensions from previously existing membranes 
and then during later stages incorporating de novo tube formation in order to hasten the 
process of tube formation in response to local oxygen demand. 
 
1.4 Factors influencing terminal branch development 
 
Tracheation is modulated by oxygen availabilty in tissues. Both hypoxia and hyperoxia are 
known to influence tracheal branching (JARECKI et al. 1999; WIGGLESWORTH 1954). Under 
conditions of low oxygen, terminal branch formation is induced, whereas in hyperoxia 
terminal branch formation is supressed. The Drosophila counterparts of the mammalian 
hypoxia-inducible factor (HIF), Similar (Sima) and Tango (Tgo) which function
 
as HIF-α and 
HIF-β homologues, activate the hypoxia induced signalling pathway (LAVISTA-LLANOS et al. 
2002). Oxygen starved tissues produce a trachaetion signal which induces tracheal branching 
in regions depreived of oxygen (WIGGLESWORTH 1954). This tracheogenic signal was later 
identified as branchless (bnl). Bnl is a potent inducer and chemoattractant of terminal 
branches that results in proliferation of terminal branches (JARECKI et al. 1999). Btl signalling 
through FGFR induces terminal branching (REICHMAN-FRIED and SHILO 1995) and also the 
expression of the downstream targets important to terminal cell development, such as 
srf/blistered/pruned/ (srf/bs). srf encodes the Drosophila homologue of the mammalian 
serum response factor and is specifically expressed in terminal cells. Mutants of srf fail to 
develop cytoplasmic outgrowths that later form terminal branches, thus severely affecting 
branching morphogenesis (AFFOLTER 1994; GUILLEMIN et al. 1996). Srf recruits the co-factor 
Elk-1( a Ternary Complex Factor, TCF) to the serum response elements (SRE) to form the 
ternary complex. FGF signalling activates MAPK pathway, activation of the MAPK pathway 
results in phosphorylation of TCFs which leads to activation of the SRE in response to 
growth factor signalling (MARAIS et al. 1993; TREISMAN 1994). Concordant with this 
observation, expression of the activated forms of Srf and Elk-1 resulted in overgrowth of 
cytoplasmic extensions and terminal branches. 
 
Screens to identify genes that affect terminal branching have revealed a few genes involved 
in maintaining normal branching and terminal cell development. (BAER et al. 2007; LEVI et 
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al. 2006). Mutants of potential cytoskeletal regulators such as Drosophila talin (rhea), the β- 
integrin myospheroid (βmys) as well as double mutants of the α-integrins inflated (if) and 
multiple edematous wings (mew) have been shown to affect maintenance of tracheal tubes 
within terminal branches (Fig.7). Mutations in ikkε also affected tube formation within 
terminal cells (OSHIMA et al. 2006). The authors speculate that these genes contribute to tube 
stability by regulating the actin cytoskeleton. Further, work from our lab has shown the 
importance of moesin (moe) in terminal cell development (Jayan N. Nair PhD thesis). Much 
work remains to be done in order to understand the mechanisms behind tube formation and 
tube stability in terminal cells. 
  
 
Figure 7: Multilumen phenotype in talin and integrin mutants 
Bright field images of terminal cells showing multilumen phenotypes in mutant of (a) talin (rhea); (b) β- 
intergrin (mys); (c) and the two α - integrins (mew and if  double mutants).  a'-c' are enlargements of the boxed 
regions in a-c respectively. Adapted from (LEVI et al. 2006). 
 
1.5 Moesin is essential for terminal cell development 
 
Moesin (Moesin) is the only Drosophila homologue of the mammalian Ezrin-Radixin-
Moesin (ERM) family of proteins. Activated Moesin (p-Moesin) acts as an anchor for F-actin 
at the apical membrane of polarised epithelia (BRETSCHER et al. 2002). Moesin is anchored to 
the membrane via various membrane anchors such as Phosphatidylinositol 4,5-bisphosphate 
(PtdIns(4,5)P2), Crumbs and Bitesize (btsz) which are used in a cell specific context (MEDINA 
et al. 2002; NAKAMURA et al. 1999; PILOT et al. 2006).  
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The activation of ERM proteins is believed to occur upon recruitment to the apical 
membrane. In Drosophila embryos, btsz is involved in maintaining epithelial integrity and the 
stabilisation of adherens junctions through its interaction with Moesin (PILOT et al. 2006). 
Knockdown of btsz in the tracheal system leads to the loss of p-Moesin (Jayan N Nair, 
unpublished) in terminal cells, indicating that Btsz is an anchor for p-Moesin in the tracheal 
system. We also know that disruption of Moesin in the tracheal system through RNAi results 
in tube formation and branching defects within terminal cells (Jayan N Nair, PhD thesis). 
Recently, the kinase activating Moesin was identified as SLK and LOK like kinase (slik) 
(HIPFNER and COHEN 2003; HIPFNER et al. 2004). In order to better understand the relation 
between anchoring and activation of Moesin at the apical membrane and its importance in 
tracheal development, I explored the function of slik in terminal cell development.  
 
1.6 slik, a Sterile 20 like kinase involved in Drosophila growth control 
 
SLK (sterile 20 like kinase) is a serine/threonine kinase and a member of the group II 
germinal centre kinases (GCKs) which includes MST1-3 (Macrophage Stimulating) and the 
LOK (Lymphocyte Oriented Kinase). SLK is cleaved by Caspase 3 in two domains with 
distinct activities: an activated N-terminal kinase domain that promotes apoptosis and 
cytoskeletal rearrangements and a C-terminal domain that disassembles actin stress fibres 
(SABOURIN et al. 2000). LOK was identified to be expressed in mammalian lymphocytes and 
to specifically phosphorylate ERM proteins. 
 
slik (SLK- and LOK like kinase), a Drosophila member of the Ste20 kinase family, was 
identified in an overexpression screen as a gene causing increased growth of the posterior 
compartment of the wing imaginal disc (HIPFNER et al. 2002). slik was named on the basis of 
its similarity to the human SLK and LOK Ste20 kinases. slik shares high sequence similarity  
to the human Slk and Lok which is largely restricted to the N-terminal kinase domain and the 
conserved coiled-coil motif bearing C-terminus (Fig.8a). The sequence internal to the 
conserved domains of Slik is non-conserved and variable in length, a feature consistent 
within members of the same subfamily. The slik transcription unit covers approximately 11 
kb and is predicted to have at least 12 exons. There are about 6 predicted transcripts based on 
cDNA clones and partial ESTs. 
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Two slik mutants, slik
1
 and slik
KG04837
,
 
have been described and used in various studies 
(HIPFNER and COHEN 2003; HIPFNER et al. 2004; HUGHES and FEHON 2006). slik
1 
represents 
a null allele which is a deletion of exons 2–8 and part of exon 9 of the slik transcript, 
including the translation start site and the entire kinase domain. slik
KG04837 
is a partial loss of 
function allele, an insertion of the P-element KG04837 in the first intron of slik (Fig.8b). slik
1
 
mutant larvae display a striking phenotype through delay in overall growth and 
developmental timing. The mutant larvae grew at the maximum up to about one-third the size 
of wild type larvae and rarely progressed beyond third instar larval phase (Fig.9). 
Intriguingly, about 5% of the mutant larvae have exceptionally long life spans of 15 days 
which is three times the normal larval phase of development.   
 
 
Figure 8: Schematic representation of Slik and the human homologues 
(a) Comparison of Slik with human SLK and LOK proteins. Numbers show sequence identity/similarity within 
the indicated domains. Predicted coiled-coil regions in the C-terminal domain are indicated by hatching; (b) 
Detailed view of the slik region. The insertion sites of EPg(2)23048 and KG04837 in the first intron and the 
extent of the slik
1
 deletion  are indicated. Adapted from (HIPFNER and COHEN 2003). 
 
 
 
Introduction  
16 
 
 
 
 
Figure 9: Growth defect in slik mutant larvae 
Heterozygous slik
1
/+ control and homozygous slik
1
 mutant larvae after 5d of growth under uncrowded 
conditions (HIPFNER and COHEN 2003). 
 
1.7 Functional relevance of slik in Drosophila development 
 
Hipfner et al. (HIPFNER et al. 2004), reported that Slik regulates cytoskeletal organisation 
during wing disc development by regulating the Drosophila ERM (ezrin/radixin/Moesin) 
protein Moesin. ERM proteins link cortical actin cytoskeleton to the cell membrane by the N-
terminal FERM domain which binds to membrane proteins directly or through adaptor 
proteins, and the C-teminal actin binding domain which binds to F-actin. Slik was shown to 
be enriched at the apical membrane in cells of the wing imaginal disc. Also, Slik colocalised 
with activated Moesin (Phosphorylated Moesin/p-Moesin) and F-actin in these cells. slik
1
 
clones in wing discs showed a considerable reduction of p-Moesin levels in comparison to 
wild type cells. Further, expression of the kinase domain of Slik (Slik
kin
) in slik mutant wing 
discs restored p-Moesin to normal levels. These results suggest that Slik kinase activates 
Moesin through its phosphorylation.    
 
Consistent with these results, in an RNAi screen in Drosophila Kc cells to identify kinases 
that activate Moesin during mitosis, slik was identified as a positive regulator of Moesin 
phosphorylation. During the onset of mitosis, cells retract their actin-based protrusion and 
change their morphology from a flattened to a rounded up form. Perturbing P-Moesin through 
slik RNAi mimicked the Moesin knockdown phenotype, i.e., failure to withdraw the actin 
rich protrusions, highlighting the importance of Slik in activating Moesin during cell division 
(KUNDA et al. 2008). 
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Recent work shows that Slik’s localisation to the apical membrane is mediated by another 
protein, SRY interacting protein 1 (Sip1) (HUGHES et al. 2010). Sip1 is the Drosophila 
homologue of mammalian EBP50 (ERM binding protein 50) that acts as a scaffold linking 
ERM proteins to transmembrane proteins and other membrane associated cytoplasmic 
proteins. Sip1 mutant follicle cells show a marked reduction of Slik levels and the subsequent 
loss of p-Moesin. On the other hand, moesin mutant cells show a drop in overall Sip1 levels, 
while slik mutant clones showed an increase in Sip1 levels. In addition, Sip1 co-
immunoprecipitates Moesin and Slik together, suggesting that both proteins form a complex 
with Sip1. Though the exact nature of the relationship between Sip1, Moesin and Slik is yet 
unknown, the authors suggest that Sip1 functions as a scaffold to bring Slik and Moesin in to 
proximity to phosphorylate Moesin (Fig.10). 
 
 
Figure 10: Possible model for Sip1 in Slik-dependent activation of Moesin. 
Inactive, folded Moesin in the cell cortex might associate with PIP2 in the plasma membrane, inducing a 
conformational change which results in partial unfolding of Moesin. This event, or other modifications such as 
phosphorylation of residues in the FERM domain (Krieg and Hunter, 1992), allow Moesin, Sip1 and Slik to 
form a complex that results in phosphorylation of the C-terminal Threonine residue and full activation of 
Moesin. Adapted from (HUGHES et al. 2010). 
 
In another study, Merlin (Mer), the Drosophila homologue of the human tumour suppressor 
Neurofibromatosis 2 (NF2) was shown to be under the control of Slik kinase (HUGHES and 
FEHON 2006). Merlin shares ~45% sequence similarity with ERM proteins and the similarity 
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is restricted to the N and C-terminal regions, which shares feature common to the ERM 
proteins and other family members. However, unlike ERM proteins that promote 
maintenance of epithelial integrity through the actin cytoskeleton (SPECK et al. 2003), Merlin 
has a distinct role in regulating cell proliferation (ROULEAU et al. 1993). Moreover, while 
ERM proteins are activated upon phosphorylation, phosphorylation of Merlin renders it 
inactive. Merlin mutant clones in eye and wings show overproliferation.  
 
Merlin has a complex subcellular localisation that spans both the apical membrane and the 
endocytic compartments within the cytoplasm (HUGHES and FEHON 2006). In wild type wing 
disc epithelium Merlin is found to localise apically. However, loss of Slik results in an 
increase in Merlin levels in the mutant cells and bulk of Merlin is redistributed to the 
basolateral regions with an increased association with punctate structures. Western blotting 
analysis with extracts from Slik and Slik kinase dead (Slik
kd
) overexpressing wing discs 
showed increased levels of phosphorylated Merlin upon Slik expression while remaining  
unchanged in Slik
kd
 expressing discs (HUGHES and FEHON 2006).  Further, activated Merlin 
suppressed wing growth, which is suppressed by removal of a copy of slik, suggesting that 
Slik antagonises Merlin function. The authors also find that Moesin and Merlin are 
competitive substrates of Slik’s kinase activity.   
 
Additionally, experiments in S2 cells with wild type, phosphomimetic and non-
phosphorylable forms of Merlin revealed a dynamic trafficking of Merlin depending on its 
phosphorylation status. In cells transfected with wild type Merlin, upon induction Merlin 
initially localised to the membrane but after 2-4 hours became enriched in endocytic 
compartments. When Merlin expression is induced in cells coexpressing Slik there is a drastic 
shift in the distribution of Merlin, with the majority localising to the membrane. In contrast, 
when Merlin expression is induced in Slik
kd
 transfected cells, Merlin localisation decreased at 
cell membranes but increased within endocytic compartments in the cytoplasm. Trafficking 
of activated/non-phosphorylated Merlin to the endocytic compartments may be of functional 
relevance in tumour suppression, by facilitating removal of receptors from cell surface that 
promote cell proliferation. expanded (ex), a Merlin-related tumour suppressor is partially 
redundant to Merlin in regulating proliferation and differentiation (MCCARTNEY et al. 2000). 
Merlin:ex double mutant cells in wing discs present abnormal accumulation of receptors such 
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as Notch and EGFR at the plasma membrane, possibly due to the lack of endocytosis of the 
receptor-bearing plasma membrane along with endocytosing Merlin fraction. Collectively, 
the activity of Slik kinase results in an orchestrated but opposite regulation of Moesin and 
Merlin to promote epithelial integrity and cell proliferation (Fig.11).  
 
Figure 11: Schematic diagram of functional relationships between Slik, Merlin, Moesin, and the 
regulation of tissue integrity and proliferation in developing epithelia. 
Slik activity simultaneously promotes Moesin function and inhibits Merlin. Previous results have shown that 
Moesin functions to negatively regulate Rho activity and promote epithelial integrity (Speck et al., 2003). 
Merlin functions to restrict proliferation in the same epithelia. Thus, the net result of Slik activity is to drive 
proliferation and simultaneously stabilise epithelial integrity (HUGHES and FEHON 2006) 
 
Apart from its kinase activity, Silk also contributes to the growth of wing disc epithelium in a 
kinase independent manner. Overexpression of Slik in the patched (ptc) domain in wing disc 
caused wing overgrowth due to increased cell proliferation. However, the Slik driven wing 
overgrowth is counteracted by an increased number of apoptotic cells. Moreover, 
overexpression of Slik
kd
 recapitulated the Slik driven overgrowth of wings suggesting that the 
Slik derived cell proliferation is through a kinase-independent mechanism. Tissue overgrowth 
resulting from Slik overexpression is suppressed through removal of the raf and the wings are 
restored to normal proportions.  
 
Apoptosis also occurs in slik mutant cells of the wing disc which is mediated by the c-Jun N-
terminal kinase (JNK) and can be suppressed by removing hemipterous (hep/JNKK) which 
encodes the activating kinase. Additionally, reduction of Raf levels in slik mutant background 
further increased the numbers of apoptotic cells suggesting that Raf is an important 
downstream effector of Slik. Since Raf was found to coimmunoprecipitate both Slik and 
Slik
kd
, the authors conclude that that activation of Raf is through its physical interaction with 
Slik, rather than phosphorylation by Slik. Finally, slik mutant cell’s growth defect can be 
rescued by expression of activated Raf, but not by activated ERK (MAPK) suggesting a 
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signalling independent of the canonical ERK pathway. Briefly, Slik functions to maintain 
epithelial integrity and promote growth through proliferation in tissues. In conclusion Slik’s 
activity is comparable to several oncogenes that promote proliferation and apoptosis in 
parallel. 
 
1.8 Aim 
 
This work aims to investigate the underlying role of Slik in tracheal development. It explores 
the contribution of Slik in terminal cell development through the phosphorylation of targets 
Moesin and Merlin. In addition, this work addresses the possible signalling input by Slik into 
the Btl/MAPK pathway, mediated through its interaction partner Raf. 
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2. MATERIALS AND METHODS 
2.1 Materials 
 
2.1.1 Drosophila melanogaster stocks 
 
w[1118]; ; embryos were used for Slik antibody stainings 
 
2.1.2 UAS Transgenes 
 
From Bloomington stock centre 
 
w[*]; P{w[+mC]=UAS-phl.gof}F179 
w[1118]; P{w[+mC]=UAS-Ras85D.V12}TL1 
 
From other sources 
 
w[1118]; ;P{w[+mC]=UAS-Slik
kin
/TM6B,Tb [1] (David Hipfner) 
w[1118]; ;P{w[+mC]=UAS-Slik
kd
/TM6B,Tb[1] (David Hipfner) 
P{hsFLP}, w[1118]; P{neoFRT}42D P {w[+mC]=tubGal80; P{w[+mC]=btl-Gal4, btl-
moesin-mRFP, UAS-CD-GFP} T(2;3)CyO -TM6 (Mirka Uhlirova) 
 
From VDRC stock centre 
 
UAS-IR-btl        VDRC 27106 
UAS-IR-egfr VDRC 107130 
UAS-IR ex  VDRC 109281 
UAS-IR-Merlin   VDRC 7161 
UAS-IR-moesin  VDRC 37917 
UAS-IR-raf        VDRC 107766 
UAS-IR-slik      VDRC 43783 
UAS-IR-srf          VDRC 100609 
UAS-IR-cad 96Cb   VDRC 103296 
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From NIG Japan 
 
UAS-IR-Ras               NIG 9375-2     
 
2.1.3 Gal4 driver lines 
 
w[1118]; P{w[+mC]=btl-Gal4}; +/+ 
w[1118]; P{w[+mC]=UAS-dicer }; P{w[+mC]= btl-Gal4}, P{w[+mC]=  UAS-GFP} 
w[1118]; P{w[+mC]=btl-Gal4}, P{w[+mC]=UAS-2XEGFP}; MKRS/TM6B,Tb[1] 
w[1118]; If/Cyo; {w[+mC]= btl-Gal4}, P{w[+mC]=  UAS-GFP} 
w[1118]; slik
1
, {w[+mC]= btl-Gal4}, P{w[+mC]=  UAS-GFP}/Cyo; MKRS/TM6B,Tb[1] 
 
2.1.4 Mutants 
 
y[1]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}slik[KG04837]/CyO; ry[506] 
w[1118]; slik
1
/Cyo, P{GAL4-kr}2, P{UAS- GFP}; 
w[1118]; P{neoFRT}42D slik
1
/CyO P{GAL4-kr}2, P{UAS- GFP}; 
 
 2.1.5 Antibodies 
 
The following primary antibodies were used: guinea pig anti-Slik (1:100, Hipfner et al 2004), 
mouse anti-SRF (1:200, DSHB), rat anti-E-Cadherin (1:200, DSHB), rabbit anti-Dof (1:200, 
Vincent et al., 1998), rabbit anti-P Moesin (1:200, S3149 Cell Signaling), rabbit anti-Moesin 
(1: 5000, François Payre), rabbit anti-GFP (1:500, Torrey Pines Biolabs Inc). Fluorophore 
conjugated secondary antibodies: Alexa468 and Alexa568 and Alexa647 (Molecular Probes) 
were used at a dilution of 1:2000. 
 
2.1.6 Oligonucleotides  
 
Btl RT_F  tccacacggaaacctcaaggacttc 
Btl RT_R acgtcgctctgtgagtcgtacttc 
bs_RT_F  cgctgcccaacaagaagtctccgcctg 
bs_RT_R   cagcttgcgcgtggcaaatgtgtaca 
Ex_RT_F              acttctggggcagcagcagccgaa 
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Ex_RT_R             gtgggtgtgcgatgatcgccagc 
Merlin _RT  tgtggctgggcgtcacctccgtg 
Merlin _RT_R      gcaggtgctccatgctcttctccag 
Moesin_F_500     cctggacaccgacgagcatatcaaggac 
Moesin _R_SalI   acgcgtcgaccatgttctcaaactgatcgacgcg 
Raf RT_F actgctgtccgcttcaatatgagcag 
Raf RT_R  ccagttttcctcggaacttttggcgt 
RpL32 RT_F tcctaccagcttcaagatgacc 
RpL32 RT_R cacgttgtgcaccaggaact 
Slik RT_F gatccgcaggtgaggcccacgacgga 
Slik RT_R  gtttgtcaatgtcttggctctgcagc 
 
2.1.7 Microscopes  
 
Olympus FV1000, Leica TCS SP2, Zeiss Axioplan 2-imaging, Zeiss Apotome and Leica M2 
16FA were used for microscopy.  
 
2.1.8 Imaging and data analysis software 
 
Image acquiring softwares FV10-ASW 2.0 Viewer, Leica Confocal Software LCS, 
Axiovision Rel 4.6 (Zeiss) and Axiovision 1 (Zeiss) were used. Images were edited using 
Adobe Photoshop (Adobe Systems) and ImageJ softwares. All images are maximum intensity 
projection unless otherwise mentioned. DNA sequence alignments, analysis and 
oligonucleotide designing were done using VectorNTI. Imaris (Bitplane) 3D/4D image 
processing software was used for 3D reconstruction of the tracheal system. 
 
2.1.9 Reagents 
 
TritonX 100, Tween20 and BSA were purchased from Sigma. Vectashield mounting media 
for fluorescent samples was from Vector Laboratories. Restriction enzymes used were from 
New England Biolabs. Expand High Fidelity PCR system was supplied by Roche 
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Diagnostics. Agarose electrophoresis grade was from Gibco BRL. Unless otherwise 
mentioned, all the other chemicals were purchased from Merck, Sigma or Roth. 
 
2.2 Methods 
 
2.2.1 Collection of embryos 
 
The flies were maintained under standard conditions (Ashburner, 1989; Wieschaus and 
Nuesslein-Volhard, 1986). 
 
To fix the embryos, an overnight egg lay (16 hr) was collected on an apple juice–agar plate, 
dechorionated using 50% bleach and washed in tap water. Embryos were fixed in 4% 
formaldehyde in PBS:heptane = 1:1 solution at 37°C for 20 minutes, with vigorous shaking, 
followed by devitellinilisation with methanol:heptane = 1:1 solution by vortexing for 30 
seconds. Embryos were washed several times in methanol and stored in methanol at -20°C if 
not used immediately.  
 
2.2.2 Immunostaining in embryos 
 
The fixed embryos were rehydrated and washed with 0.3% PTX (1XPBS+ 0.3% TritonX 
100) three times for 10 min each followed by 30 min incubation in blocking reagent (1X 
PBS+ 0.1% TritonX 100 + 1% BSA). After blocking, the liquid phase was taken off and the 
primary antibody was added to the embryos. The samples were left at 4°C overnight, on a 
rotating wheel. Embryos were washed with 0.3% PTX several times, at room temperature 
followed by incubation with Alexa coupled secondary antibody at room temperature for 90 
minutes. The embryos were washed four times (15 minutes each) in 0.3% PTX at room 
temperature and mounted in Vectashield before imaging.  
 
2.2.3 RNAi in the tracheal system  
 
Crosses were set up using the UAS-RNAi transgenic line and the btlGal4, UAS-GFP 
recombinant driver line, with UAS-dicer or excluding UAS-dicer in cases where 
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coexpression of UAS-dicer caused lethality or resulted in extremely small larvae. The crosses 
were maintained at 29°C unless otherwise mentioned. Wandering third instar larvae were 
collected and dissected to expose the tracheal system. Larvae were fixed using 4% 
paraformaldehyde in PBS for 20 minutes and washed with 0.3% PTX (1XPBS+ 0.3% 
TritonX 100) followed by mounting the larval fillets using Vectashield. In case where 
antibody staining was required the larvae were subjected to the antibody staining protocol 
described below. 
 
2.2.4 Immunostaining in larvae 
 
Post fixation fillets were washed with 0.3% PTX (1XPBS+ 0.3 % TritonX 100) three times 
for 10 min each followed by 30 min incubation in blocking reagent (1X PBS+ 0.1% TritonX 
100 + 1% BSA). After blocking, the samples were incubated overnight in antibody solution 
at 4°C. Fillets were washed four times (15 minutes each) in 0.3% PTX after overnight 
incubation. Fillets were incubated in Alexa fluorophore conjugated secondary antibodies for 
2 hours at room temperature. Next, the fillets were washed four times (15 minutes each) in 
0.3% PTX at room temperature, mounted in Vectashield and taken for microscopy. 
 
2.2.5 Generation of slik
1 
MARCM clones in the tracheal system 
 
Crosses were set up using the appropriate stocks and maintained at 25°C. A 24-hr egg lay 
collection was taken and heat shocked for about 2 hours. After heat shock the tubes were 
placed at 29°C. Around day 5-6 post egg lay, wandering third instar larvae were collected, 
dissected and mounted on slides as described in the previous section. 
 
2.2.6 Tracheal cDNA synthesis 
 
Wild type third instar larvae were dissected, the tracheal system was isolated and the tissue 
macerated in Trizol (Invitrogen).  RNA was isolated using the standard Trizol-based isolation 
protocol. RNA isolated was treated with DNase according to manufacturer’s protocol 
(Invitrogen). 200 ng of RNA was used for cDNA synthesis using First strand synthesis 
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kit/SuperscriptIII according to manufacturer’s instructions (Invitrogen) using a 1:1 mix of 
both random hexamers and oligo dT. 
 
2.2.7 RT PCRs 
 
1 l of the tracheal cDNA was used as the template for PCR reactions. The reaction 
components were: 20 pmols of each primer, 1X Red Taq Readymix (Sigma) in a 20 l PCR 
reaction mix. The PCR was carried out on a Thermoblock (Biometra). The PCR programme 
included a denaturation step of 2 minutes at 94°C followed by 30 cycles: 15 seconds at 94°C, 
30 seconds annealing at 57°C, 30 seconds extension at 72°C. No final extensions were 
included in the programme. The PCR products were analysed on a 1.5% agarose gel.  
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3. RESULTS 
3.1 Slik is required for tracheal development 
 
Studies on tracheal development and more specifically on terminal cells have outlined the 
importance of Moesin in tube formation and maintenance of the tube within the branches. 
One of the factors that regulate Moesin in other tissues is the Moesin activating kinase Slik, 
implicated in wing imaginal disc development, mitotic events in S2 cells and normal 
development of follicle cells of oocytes (HIPFNER et al. 2004; HUGHES and FEHON 2006; 
HUGHES et al. 2010). This study explores the function of Slik in terminal cell development in 
conjunction with Moesin and another signalling molecule, Raf. 
 
3.1.1 Slik is expressed in both the embryonic and the larval tracheal system 
 
To analyse Slik distribution in the tracheal system, I used an antibody against Slik (HIPFNER 
and COHEN 2003). This antibody was previously used to examine Slik localisation in wing 
discs, oocytes and mitotic S2 cells (CARRENO et al. 2008; HIPFNER et al. 2004; HUGHES et al. 
2010). Stainings from these studies showed that Slik was enriched at the apical membrane of 
cells in the wing imaginal disc and also in the follicular epithelium of oocytes. In mitotic S2 
cells Slik is localised at the mitotic cortex of the dividing cells. To mark the tracheal cells 
antibodies against Dof was used. Dof is an adaptor protein specific to the two FGFRs, 
breathless (btl) and heartless (htl) which are active in the tracheal system and the migrating 
mesoderm, respectively (VINCENT et al. 1998). Dof is expressed through all stages of tracheal 
development. The distribution of Slik and Dof was visualised using secondary antibodies 
coupled to fluorescent (Alexa Fluor®) dyes (Fig.12).   
 
At embryonic stage 10, tracheal development commences with the invagination of the 
tracheal placodes within each segment. In the invaginating tracheal placode, cells constrict 
their apical surface which is the concave side of the depression. Staining for Slik reveals that 
Slik is expressed in the invaginating placode with enrichment at the apical side of the cell 
(Fig.12a). In stage 12 embryos, cells within the migrating placode continue to have an apical 
enrichment of Slik (Fig.12b). At stage 14 of development, cells from each placode migrate 
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and are arranged side-by-side and interdigitate to form a continuous tube. At this stage of 
tracheal development Slik enrichment persists at the apical regions of cells forming the tube, 
i.e. the membrane facing the lumen of the developing tube (Fig.12c.)  Also, previous studies 
in wing imaginal discs reported Slik to be enriched at the apical membrane of the cells 
(HIPFNER et al. 2004). 
 
 
Figure 12: Slik expression during embryonic development of the tracheal system 
Tracheal cells are visualised by anti-Dof staining (a-c). (a) Slik expression during tracheal placode invagination 
at stage 10; (b) Outgrowth of primary branches at stage 12 and (c) Stage 14. Slik expression shows strong apical 
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enrichment within the trachea. a', b' and c' are enlargements of the corresponding stages in a, b and c. Scale a, b, 
c - 50 µm and a', b', c' - 10 µm. 
 
At the end of embryonic development, patterning of the tracheal system is complete with the 
dorsal trunk, the dorsal branches, the lateral branches and the terminal cells in place. 
Terminal cells at this stage are morphologically distinct from those found in larvae as they  
possesses only a single branch extension with a tube within. Over the larval phases of 
development these cells generate multiple branches to form a functional terminal cell. 
Branching events in a terminal cell alter the morphology of the cell from a simple cell to a 
cell that is highly ramified and spanning over a large area (Fig.13). The tips of these branches 
establish direct contact with tissues requiring oxygen. 
 
 
Figure 13: A terminal tracheal cell from a larva at third instar phase of development 
Tracheal cells are visualised by tracheal specific cytoplasmic GFP expressed using btlGal4. The terminal cell is 
highly branched and carries a tube within each branch (arrows). Oxygen is transported through these tubes to 
surrounding tissues and organs. Star denotes the cell nucleus. Also seen are parts of the secondary branches 
from adjacent areas (marked by dots). Scale - 50 µm.  
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To analyse the distribution of Slik in the terminal branches, Slik staining was performed in 
larvae expressing the UAS-GFP transgene in the tracheal cells using the tracheal specific btl-
Gal4 line. The GFP is expressed in both the nucleus and the cytoplasm and hence is used to 
highlight the tracheal system. Staining for Slik in third instar larvae showed that Slik is 
expressed in the terminal cells (Fig.14a). Further, high resolution imaging showed that Slik is 
enriched at the apical membrane within the terminal branches, with occasional diffused 
staining at sub-apical regions (Fig.14b).  
 
 
 
Figure 14: Slik expression in terminal cell of the tracheal system 
Tracheal cells are visualised by tracheal specific cytoplasmic GFP expressed using btlGal4 (a, b). (a) Slik 
expression in a terminal cell; (b) Enlargement of the corresponding area in image a (boxed) showing Slik 
enrichment in the apical membrane of the branch. Scale a - 25 µm, b - 10 µm. 
 
Next, I investigated the localisation of Slik within cellular junctions of the tracheal system. 
The tracheal terminal cells are junctionless cells except for a junction connecting terminal 
cells to the secondary branch. However, the dorsal trunk is a multicellular tube and therefore 
suited for studies on junctions within the tracheal system. Of particular ease in studying 
junctions within the tracheal system are the fusion cells, a pair of doughnut shaped cells that 
form the anastomoses of the dorsal trunk (Fig.4). In epithelial cells E-Cadherin (E-Cad) is 
localised to the apicolateral regions where it is a component of the adherens junction. In order 
to mark the junctions within the dorsal trunk I performed immunostaining for E-Cad. At the 
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point of fusion of the dorsal trunk E-Cad is expressed in 3 stripes, the central stripe which 
marks the adherens junction formed at the point of contact between fusion cells and the two 
other flanking stripes that delineate the junction between the fusion cell and the dorsal trunk 
at either side (Fig.15b). Analysis of the dorsal trunk for Slik protein expression shows that 
Slik is expressed in the fusion cells of the dorsal trunk (Fig.15a). A simple maximum 
intensity z-projection of images of the dorsal trunk was not sufficient to determine the 
localisation of Slik in relation to the junction. Therefore, I performed 2D reconstruction of the 
dorsal trunk using Imaris imaging software. 2D reconstruction of the dorsal trunk revealed 
that Slik expressed in the fusion cell localised to the apical membrane of the fusion cells. 
Optical sections across various planes of the dorsal trunk showed that the localisation of Slik 
was more apical to E-Cad at the lumen (Fig.15c). This result is consistent with the results 
from a previous study where the authors observed that Slik localised apical to the adherens 
junction in wing disc epithelium (HIPFNER et al. 2004) 
 
3.1.2 Slik is required for normal branching, lumen formation and tube 
stability in terminal cell development 
 
To investigate the function of slik in tracheal development, slik
1 
mutant larvae were analysed.  
slik
1
 is a null allele as it is a deletion that removes exons 2–8 and part of exon 9. This deletion 
removes the translation start site and the entire kinase domain. slik mutant clones of terminal 
cells were generated through the MARCM method. Also, I performed tracheal specific 
knockdown of slik through RNAi and analysed the outcome. Results from experiments using 
various approaches showed similar phenotypes and are discussed in the following sections. 
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Figure 15: Slik expression in fusion cells of the dorsal trunk  
Tracheal cells are visualised by tracheal specific cytoplasmic 
GFP (green), antibodies specific for Slik (red) and E-Cadherin 
(Cad) (blue). a and b are maximum intensity projections. (a-a''') 
A segment of the dorsal trunk showing fusion anastomosis 
(boxed). The fusion cells are two ring shaped cells connecting 
the multicelluar dorsal trunk from each segment. (a') Slik is 
expressed at high levels in fusion cells; (a'') E-Cad at the fusion 
point is seen as three stripes, marking junctions between the 
fusion cells and that between the fusion cells and the 
multicellular tube; (a''') overlay of Slik and E-Cad; (a'''') 
overlay of GFP, Slik and E-Cad. (b-b'') Enlargement of boxed 
area in a'''; (c-c'') 2D projection of the dorsal trunk showing 
apical localisation of Slik; view of the dorsal trunk centred at the 
fusion anastomosis along (c) the XY plane; (c') the YZ plane 
(sagittal section) shows Slik localisation apical to E-Cad 
localisation. (c'') View across the XZ (transverse section) plane 
shows that Slik is localised more apical to E-Cad. Inset-  
magnified view of indicated region. Scale a - 25 µm, b - 10 µm 
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3.1.2.1 Analysis of the tracheal system in slik
1
 mutant animals 
 
slik
1 
homozygous mutants are larval lethal and therefore very few escapers of the 
homozygous mutant larvae were obtained. The escaper slik
1
 mutant larvae had a smaller body 
size (Fig.16), which was consistent with previous observation (HIPFNER and COHEN 2003). 
 
slik
1 
homozygous third instar larvae were filleted and processed. The larvae showed gross 
abnormalities in the tracheal system. The dorsal branches showed lumen defects. In a wild 
type dorsal trunk the multicellular tube is composed of cells arranged with their apical 
surfaces facing the lumen. The apical surface of the tracheal cells expands permitting tube 
dilation and at the same time secretes chitin to reinforce the expanding tube. A bright field 
image of the wild type dorsal trunk showed that the lumen diameter spans almost the entire 
width of the dorsal trunk. By contrast, bright field images of the dorsal trunk from a slik
1
 
mutant larva showed lumen defects. While the outer diameters of the dorsal trunk from both 
wild type and mutant larvae were comparable, the diameter of the lumen in the mutant was 
less than half as wide as in the wild type. The presence of a narrow lumen despite of the 
normal branch size indicated a failure in lumen expansion within the mutant dorsal trunk 
(Fig.17a', b').  
 
To further analyse tracheal phenotypes in slik
1
 mutants, the terminal cells from these larvae 
were compared with the wild type cells. The mutant terminal cells showed defects in 
branching. Wild type terminal cells on an average had over 20 branches, whereas in slik
1
 
mutant cells branching was restricted to fewer than 10 branches (Fig.13 and 18). In addition 
to reduction in number of branches the mutant terminal cells also exhibited luminal defects. 
Normally in terminal cells each branch bears a single lumen but in the mutant terminal cells 
multiple lumens were observed, either within a single branch or clustered near the nucleus. 
This phenotype is henceforth addressed as the mutilumen phenotype (Fig.18c').   
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Figure 16: slik
1
mutant larvae show altered body size 
Larvae in the image above have been dissected on their ventral side to expose the tracheal system. (a) wild type 
third instar larva; (b) and (c) are  slik
1
mutant larvae also at third instar larval stage as judged by the presence of 
completely extruded anterior spiracles with spiracular papillae,  but exhibiting smaller body sizes. 
 
 
 
 
Figure 17:  slik
1
 mutant larvae show tube defects within the dorsal trunk  
slik
1
 mutant tracheal system is visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4 
and tubes within the trachea are visible in bright field (BF) (a, b). (a-a'') Dorsal trunk from a wild type larva; 
(b-b'') dorsal trunk from a slik mutant larva. (a') Bright field image of the wild type  trachea shows that the 
dorsal trunk and the tube within are almost of the same diameter and therefore not clearly visible as two distinct 
components. (b') Dorsal trunk from a slik mutant larva shows that the dorsal trunk and the tube (marked by 
short and long arrow respectively) are easily identified. The tube within the dorsal trunk is not centrally 
positioned and has not expanded sufficiently to line the inner wall of the dorsal trunk. Scale - 50 µm. 
. 
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Figure 18: Terminal cells from slik
1
 mutant third instar larvae show branching and lumen defects 
Tracheal system is visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4. (a-c) 
Terminal cells from slik
1
 mutant larvae show reduced branching. (c') Enlargement of the corresponding area in 
image c (boxed), showing multilumen (multiple tubes within a branch) phenotype. Scale - 25 µm. 
 
3.1.2.2 Analysis of slik
1
 MARCM clones in the tracheal system  
 
In addition to analysis of the slik
1 
mutant tracheal system, slik
1
 mutant clones were generated 
in the tracheal system using the MARCM (Mosaic Analysis with a Repressible Cell Marker) 
technique. I chose this approach due to the unavailability of sufficient numbers of 
homozygous mutant third instar escapers, coupled with the difficulty of dissecting small sized 
larvae. The mutant terminal cells express GFP which distinguishes these cells from the 
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neighbouring wild type cells. Very few terminal cells (MARCM clone) of the mutant 
genotype were obtained indicating that slik is required for cell survival. The few MARCM 
clones that survived showed abnormal terminal cell development. Like terminal cells from 
slik
1
 homozygous mutant larvae, mutant terminal cells from the MARCM clones displayed 
tube and branching growth defects. The mutant terminal cell had fewer branches (Fig.19a,b). 
Clonal slik
1
 terminal cells also showed the multilumen phenotype (Fig.19a) as observed with 
slik
1
 homozygous mutant larvae. These results indicated that slik definitely has a role in 
branching morphogenesis of terminal cells. 
 
 
 
Figure 19: slik
1
 MARCM clones in the tracheal system from third instar larvae  
slik
1 
mutant clonal terminal cells generated by MARCM technique express cytoplasmic GFP. (a-a'') A terminal 
cell showing multilumen phenotype (marked by an arrow); (b-b'') mutant terminal cell showing reduced 
branching phenotype, Scale a -25 µm and b - 10 µm 
 
 
Given the low frequency of occurrence of the MARCM clones and the difficulty in working 
with slik
1
 mutant larvae that barely grew in size, RNAi mediated knockdown of slik was 
employed to study the slik mediated terminal cell development.  
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3.1.2.3 Analysis of slik mutant tracheal system using RNAi  
 
An alternate in vivo strategy to study the function of genes is to deplete the protein by 
knocking down the gene products within tissues. Slik levels in the tracheal system were 
depleted using slik RNAi constructs expressed specifically in the tracheal system using 
btlGal4. Two slik RNAi lines were tested in the tracheal system, VDRC 43783 and VDRC 
43784. Since both these lines had a potential off-target, pKC98E, RNAi for this gene in the 
tracheal system was performed as control. Knockdown for pKC98E did not result in any 
observable phenotypes; therefore I concluded that knockdown of slik using these lines gives 
only Slik specific phenotypes. Knockdown of slik using both lines resulted in similar 
phenotypes; therefore all further experiments were performed using line VDRC 43783. 
 
The knockdown of slik resulted in a similar phenotype as seen in slik
1 
mutants. The most 
obvious effect of slik knockdown in the tracheal system was the reduction of the larval body 
size (Fig.20), but still larger than slik
1
 mutant larvae. Moreover, the larvae had substantially 
smaller fat bodies than a wild type animal which gave the larvae a more transparent 
appearance. Reduction in body size could be an effect of reduced metabolism resulting from 
a deficit in oxygen supply due a physiologically inefficient tracheal system as a result of 
defective terminal branching. Next, I investigated if slik knockdown affected terminal cell 
differentiation.  
 
To address this, immunostainings with antibodies against Drosophila Serum response factor 
(Srf) was performed. Srf is a transcription factor expressed only in terminal cells among all 
tracheal cells. srf is also expressed in muscle nuclei, but since the tracheal system is marked 
by GFP the terminal cells nuclei can be identified by the overlay (Fig.21). Terminal cells 
identified by Srf expression were counted in five animals from both wild type and slik RNAi 
animals. Terminal cells from the tracheal segments tr3-5 were counted which were located by 
the presence of tracheoblast at the dorsal trunk (Fig.21). The results from these cell counting 
experiments showed that the number of terminal cells, both in wild type and slik RNAi, were 
comparable. (Fig.22, Appendix Fig.50). The average terminal cells count in both genotypes 
were as follows, wild type = 29.2 ± 2.68, slik RNAi = 31± 3.08. The p value from a Student’s 
t-test was p = 0.35. Thus branch counting showed that slik knockdown in the tracheal system 
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does not interfere with the specification of terminal cells but rather with the development of 
terminal cells and branches. 
 
  
Figure 20: Knockdown of slik in the tracheal system affects larval body size 
Comparison of third instar slik knockdown larva with a wild type larva of the same stage. The larvae were raised 
at 29°C. Third instar larva were identified by the presence of the characteristically exposed spiracular papillae of 
the anterior spiracles. Tracheal specific knockdown of Slik reduced body size in larvae.  
 
 
 
Figure 21: Dorsal terminal cells of the tracheal segments tr3-tr5 from third instar larvae  
Tracheal system is visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4 and the 
terminal cells are identified by Srf staining (red). (a) Schematic representation of the tracheal system in a third 
instar larva, marking tracheal segments tr3, tr 4 and tr5. (b) An assembly of a series of snapshots that cover tr3, 
the specific tracheal segment is identified by the presence of tracheoblasts (blue dots) while the preceding 
tracheal segment lacks the tracheoblast. Terminal cells express Srf (marked by arrows) and therefore in this 
overlay are seen as yellow. 
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Figure 22: Average terminal cell counts in wild type and slik RNAi trachea 
Third instar wild type and slik RNAi larvae were dissected and the terminal cells from tracheal segments tr3-5 
were counted. Terminal cells from five animals were counted for each genotype and the bars represent the 
average of terminal cells counted. The average values were as follows wild type = 29.1 and slik RNAi = 31. A 
Student’s t-test gave the value p = 0.35. 
 
 
 
Figure 23: Knockdown of slik in the tracheal system affects branching in terminal cells  
(a, b) Terminal cells from a slik knockdown larva show reduced branching with branch points varying between 
(a) 6 and in an extreme case (b) 2 branches. Branching points were counted by scoring branches that possessed 
a lumen that was connected to the parent/previous branch’s lumen. Scale - 50 µm. 
  
Analysis of terminal cells in slik knockdown larvae revealed multiple defects. First, terminal 
cells in knockdown larvae showed an overall reduction in branching. Consistent with slik
1 
mutants and MARCM clones, on average fewer than 10 branches per terminal cell were 
observed compared to about 20 branches per cell in the wild type (Fig.23a). In some terminal 
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cells the knockdown resulted in severe branching defects such that the terminal cells were 
restricted to just two branches (Fig.23b). In addition to the branching phenotype, the terminal 
cells also showed tube abnormalities. Knockdown of slik in terminal branches lead to the 
formation of multiple lumens (multilumen phenotype) within the branches (Fig.24), as also 
observed in slik
1 
mutants.  
 
 
Figure 24: Knockdown of slik in the tracheal system affects lumen formation in terminal cells 
Tracheal system is visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4. Terminal 
cell branches show multiple lumens upon slik RNAi in the tracheal system. The multiple tubes/lumens are 
marked by arrows. Scale - 25 µm. 
 
3.2. Slik, Moesin and Merlin in tracheal development 
 
We know that Slik is expressed in the tracheal system and enriched at the apical membrane 
within branches of the terminal cell. Further, Slik is essential for terminal cell development as 
mutants for slik do not have normal branch and lumen formation. Earlier reports have 
described Moesin and Merlin as two known targets of Slik (HIPFNER and COHEN 2003; 
HIPFNER et al. 2004; HUGHES and FEHON 2006). Slik phosphorylates both these proteins and 
regulates their activity in various cellular processes. slik RNAi phenotypes could arise as a 
result of loss of Slik’s function over Moesin and Merlin. To address this possibility I looked 
at moesin and Merlin expression in the tracheal system. 
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3.2.1 Moesin and its activated form (p-Moesin) are expressed in the 
tracheal system 
 
Slik is known to activate Moesin through phosphorylation and activated Moesin (p-Moesin) 
stabilises filamentous actin by anchoring it to the plasma membrane (POLESELLO et al. 2002). 
Phosphorylation of Moesin induces conformational changes in the protein, from closed to 
open state, thereby activating and facilitating its interaction with the actin cytoskeleton. 
Multiple lumens can be associated with loss of stabilisation of actin cytoskeleton as a result 
of depletion of the crosslinker proteins (LEVI et al. 2006). Thus disruption of Moesin function 
by knockdown of its activating kinase could lead to tube destabilisation within branches 
resulting in the multilumen phenotype. This is supported by evidence from previous work 
which that showed knockdown of Moesin in the tracheal system resulted in reduced 
branching and multiple lumen phenotypes in terminal cells (Jayan N.Nair, PhD Thesis). Since 
Slik is critical in terminal cell development, I examined the subcellular localisation of 
Moesin.   
 
 
Figure 25: Moesin is expressed in terminal cell of the tracheal system 
Tracheal cells are visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4 (a, b) and 
antibodies specific for Moesin (in red) (a', b'). (a-a') Overview of a terminal cell; (b-b') enlargement of the 
corresponding area in image a (boxed) showing Moesin enrichment in the apical membrane of the branch. Scale 
a - 50 µm, b - 10 µm. 
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Immunostaining using antibodies against Moesin was performed on third instar larval fillets 
expressing UAS-GFP in the tracheal system. The stainings showed that Moesin was 
expressed in the tracheal system. Moesin was found enriched at the apical membrane within 
terminal cell branches (Fig.25). As Moesin is also expressed in all other tissues, Moesin from 
the underlying muscle tissue was also detected.    
 
Fly Moesin is phosphorylated at amino acid residue Threonine
556
 and so far Slik is the only 
kinase known to regulate this phosphorylation. To visualise activated p-Moesin in terminal 
branches, an antibody that specifically recognised phosphorylation at T
556 
of Moesin was 
used. Immunostainings showed that p-Moesin was enriched at the apical membrane of 
terminal cells. The results were consistent with the earlier published data where 
immunostainings in wing discs showed p-Moesin enriched at the apical membrane (HIPFNER 
et al. 2004)  
 
 
Figure 26: Phosphorylated-Moesin expression in terminal cell of the tracheal system 
Tracheal cells are visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4 (a, b) and 
antibodies specific for the phosphorylated form of Moesin (red) (a', b'). (a-a') Overview of a terminal cell; (b-
b') enlargement of the corresponding area in image a (boxed) showing p-Moesin enrichment in the apical 
membrane of the terminal branch. Scale a - 50 µm, b - 10 µm 
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A previous study on p-Moesin in the tracheal system (Jayan N. Nair 2008, PhD thesis) has 
shown that p-Moesin is localised at the apical membrane, which was confirmed here for the 
terminal cells (Fig.26). p-Moesin expression was also analysed in the dorsal trunk. The dorsal 
trunk showed a clear enrichment of p-Moesin at the junctions between fusion cells and those 
between the dorsal trunk and the fusion cells, visible as diffuse stripes (Fig.27). These 
experiments confirm that activated Moesin is expressed in the tracheal system and shows a 
clear apical membrane localisation in terminal cells and junctions of the fusion cells in the 
dorsal trunk. 
  
 
Figure 27: Phosphorylated Moesin is expressed in fusion cells of the dorsal trunk 
Tracheal cells are visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4 and 
antibodies specific for the phosphorylated form of Moesin (red) (a, b). (a-a') p-Moesin expression in dorsal 
trunk; (b-b') enlargement of the corresponding area of the dorsal trunk (boxed) showing p-Moesin enriched 
within the fusion cells. Scale a - 20 µm, b - 10 µm. 
 
3.2.2 Merlin is expressed in the tracheal system 
 
Merlin the Drosophila homologue of the human Neurofibromatosis 2 (NF2) tumour 
suppressor is also a target of Slik’s kinase activity. In the Drosophila embryonic epithelium 
Merlin is expressed as punctae both at the apical membrane and the cytoplasm (MCCARTNEY 
and FEHON 1996). expanded (ex) is a tumour suppressor closely related to Merlin. Ex and 
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Merlin has been shown to function in a redundant manner participating in receptor 
endocytosis and trafficking (MAITRA et al. 2006). The subcellular distribution of Merlin in 
the tracheal system could not be analysed by immunostaining due to unavailability of the 
antibody. Therefore, I tested for the presence of Merlin in trachea by reverse transcription 
PCR (RT-PCR). Tracheae from wild type larvae were dissected and total RNA was isolated 
from the dissected samples. cDNAs were synthesised by reverse transcription reaction 
followed by detection with PCR with oligonucleotides specific for slik, moesin, Merlin and 
ex.  
 
Oligonucleotides used spanned over two exons so that amplicons from both genomic DNA 
and transcripts were identifiable as genomic products were larger than the products amplified 
from transcripts. As control, ribosomal protein L32 (RpL32), a component of the 60S subunit 
of the ribosome was used. The results showed that in addition to slik and moesin, as observed 
with immunostaining, both Merlin and its interaction partner ex were indeed expressed in the 
tracheal system (Fig.28).  
 
 
Figure 28: slik, moesin and Merlin are expressed in the Drosophila tracheal system 
RT-PCR using tracheal cDNA shows that slik, moesin and Merlin are expressed in the tracheal system. The 
products here are amplicons from cDNA as they are of expected sizes. The control, RpL32 encodes for the 
ribosomal protein L32. The RT-PCR shows that Expanded, a protein distantly related to Merlin and also an 
interaction partner of Merlin is expressed in the tracheal system. 
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Figure 29: Slik and phosphorylated Moesin colocalise at the apical membrane within terminal cell branches 
(a-a''') Tracheal cells are visualised by tracheal specific cytoplasmic GFP (green), antibodies specific for Slik (red) and the phosphorylated form of Moesin (p-Moesin) 
(blue). (b -b''') enlargement of the corresponding area in image a (boxed) showing; (b) Slik - Moesin colocalisation at the apical membrane; (b') Slik and (b'') p-Moesin 
enrichment at apical membrane; (b''') overlay of GFP, Slik and p-Moesin. Positions at which all three proteins are present are seen as white in the overlay, and are 
restricted to the apical membrane of the cell.  Scale a - 50 µm, b - 5 µm. 
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3.3 Slik and Moesin colocalise at the apical membrane in terminal cells  
 
The above observations from immunostainings and RT-PCRs have confirmed the expression 
of Slik and its phosphorylation targets Moesin and Merlin in the tracheal system. To 
investigate if Moesin was indeed a target of Slik in the tracheal system like in other tissues, I 
first investigated the localisation of these two proteins by double labelling with both anti-Slik 
and anti-p-Moesin antibodies. The stainings were performed in larvae expressing cytosolic 
GFP in the tracheal system under the btlGal4 driver (Fig.29). The immunostainings were 
visualised by detection with secondary antibodies coupled to fluorophore (Alexa Fluor®) 
dyes. Analysis of the immunostainings revealed that Slik and Moesin colocalised at the apical 
membrane of terminal branches (Fig.29b), which was consistent with earlier reports on wild 
type wing imaginal discs (HIPFNER et al. 2004).  
 
3.4 Knockdown of moesin in the tracheal system results in phenotypes 
similar to slik RNAi 
 
Moesin plays multiple roles in Drosophila development and is involved in processes such as 
oocyte anterior/posterior axis specification (JANKOVICS et al. 2002), actin cytoskeleton 
organization (KUNDA et al. 2008), establishment or maintenance of epithelial cell apical/basal 
polarity of larval imaginal disc epithelium (SPECK et al. 2003) and  rhabdomere development 
(KARAGIOSIS and READY 2004). In addition, Moesin is regulated by Slik kinase activity. As 
moesin mutant animals are not viable, I used moesin RNAi constructs to study the effect of 
Moesin depletion in the tracheal system.  The moesin RNAi construct VDRC 37917 was used 
along with UAS-dicer and UAS-GFP driven by btlGal4 to have a tracheal specific 
expression. However, only very few progeny grew up to third instar larval stages and these 
were comparable in size to a wild type first instar larva. To reduce the severity of the 
knockdown phenotype I performed the knockdown without expressing dicer. The larvae thus 
obtained were of moderate size and suitable for dissection.  
 
moesin mutant terminal cells exhibited abnormal branching and lumen phenotypes as 
observed in case of slik knockdown. The number of branches in terminal cells of moesin 
mutant larvae was significantly reduced compared to wild type larvae (Fig.30). Moreover, the 
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mutant terminal cells also showed the multilumen phenotype (Fig.30b) though the phenotype 
was not completely penetrant. Apart from slik mutants, multilumen phenotype has also been 
reported with mutants for bitesize (btsz). A previous study showed that Btsz protein localised 
apically in epithelial cells and was required for recruiting Moesin to the adherens junctions 
(PILOT et al. 2006). Work from our lab showed that btsz RNAi in tracheal cells lead to 
destabilised tubes and similar branching defects (unpublished data Jayan N. Nair Appendix 
Fig.49).   
 
 
Figure 30: Effect of moesin RNAi on terminal cells 
moesin RNAi transgene was expressed in trachea marked with cytosolic GFP. Terminal cells from a third instar 
moesin knockdown shows (a) a terminal cell with few branches; (b) a terminal cell displaying the multilumen 
phenotype, multiple lumens are marked by arrows. Scale a - 50 µm, b - 25 µm 
 
3.5 Knockdown of Merlin and expanded in the larval tracheal system 
 
Previous studies showed that Slik negatively regulated Merlin through phosphorylation.  
Since RT analysis of the tracheal system confirmed the expression of Merlin, I investigated 
whether Merlin has any role in larval tracheal development. For this purpose, Merlin RNAi 
construct VDRC 7161 was used along with the UAS-dicer and UAS-GFP driven by btlGal4 
to achieve tracheal specific expression. Knockdown of Merlin in the tracheal system did not 
affect the larval growth unlike the slik and moesin knockdowns, more importantly the 
knockdown did not result in branching defects as seen with slik and moesin RNAi.  
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However, Merlin knockdown resulted in terminal cells with abnormal morphology. To 
exclude the possibility that the phenotype was an off-target effect, I tested the predicted off-
target Cad96Cb as control. RNAi for Cad96Cb did not result in any tracheal phenotypes. 
Terminal cells from Merlin knockdown larvae showed a phenotype different from those 
observed previously for slik or moesin. Terminal branches were larger in comparison to the 
wild type branches. Though the terminal cell nuclei were of comparable sizes, the branches 
from Merlin depleted cells appeared to have large amounts of cytoplasmic material (Fig.31). 
This phenotype was unexpected, but fits with the known function of Merlin, a tumour 
suppressor. Merlin mutants tissues and organs are known to grow to enormous sizes (YI and 
KISSIL 2010).  
 
 
 
Figure 31: Effect of Merlin RNAi in larval terminal cells 
Tracheal system is visualised by tracheal specific cytoplasmic GFP (green) expressed using btlGal4. (a) Wild 
type terminal cell; (b) terminal cells from a Merlin knockdown larvae showing increased cytoplasm in the 
branches. Note nuclei (marked by arrows) are of comparable sizes. Scale - 50 µm. 
 
Since Merlin RNAi did not result in any phenotypes similar to either slik and/or moesin 
knockdowns, I investigated if the difference was due to the presence of Ex the interaction 
partner and a protein functionally redundant to Merlin. To determine if Ex had any role in 
terminal cell development, ex specific RNAi construct was expressed in the tracheal system. 
The line used in the experiment was VDRC 109281, which had no predicted off-targets. 
However, the knockdown of ex in trachea did not result in any observable phenotype 
whatsoever. This suggests that Ex has no function in terminal cell development. 
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Alternatively, since ex RNAi knockdown was performed alone, the possible compensation by 
Merlin for the loss of Ex in trachea cannot be ruled out. 
 
3.6 Knockdown of slik leads to loss of activated Moesin in terminal cells 
    
Moesin is activated by phosphorylation on the conserved threonine residue (T
556
) in the C-
terminal domain of the protein. It is known that Slik can phosphorylate Moesin and that 
activated Moesin (p-Moesin) is lost in slik
1 
clones and on slik RNAi in S2 cells. To study the 
phosphorylation of Moesin in slik mutant terminal cells, I performed immunostainings with 
the p-Moesin antibody in third instar larvae. Third instar larvae expressing UAS-slik RNAi 
(VDRC 43783), UAS-GFP and UAS-dicer under the btlGal4 were dissected to analyse the 
tracheal system. p-Moesin staining was performed on slik depleted and as well as wild type 
larvae.  
 
 
 
Figure 32: Effect of slik RNAi on p-Moesin levels in larval terminal cells 
Terminal cells from larvae of the genotypes (a-a'') wild type; (b-b'') slik RNAi, visualised by tracheal specific 
cytoplasmic GFP (green) and p-Moesin (red).  p-Moesin expression is lost in terminal cells of a slik knockdown 
larva (a'and b'). p-Moesin is expressed in all tissues therefore Moesin from surrounding tissues is also detected.  
Scale - 25 µm. 
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In wild type terminal cells, p-Moesin was localised at the apical membrane of the terminal 
cell branches (Fig.32a). However, in slik mutant terminal cells, the apical localisation of p-
Moesin was completely lost (Fig.32b), consistent with loss of p-Moesin in the slik
1
 clones in 
wing disc. Even with increased exposure parameters while imaging no p-Moesin was 
detected in the terminal branches in case of mutants, which is substantiated by the effect of 
increased signal from underlying muscle tissue exceeding levels seen in wild type (compare 
Fig.32a' and b'). As all tissues express p-Moesin, p-Moesin is detected from underlying 
muscle tissues. These results confirm that Slik regulates p-Moesin expression/localisation at 
the apical membrane in the terminal cells and that loss of Slik leads to the subsequent loss of 
p-Moesin from terminal branches. The results are consistent with previously published data 
from wing disc (HIPFNER and COHEN 2003; HIPFNER et al. 2004). 
 
3.7 Slik’s kinase function is critical in terminal cell lumen formation 
 
Loss of Slik from the tracheal system lead to the loss of phosphorylated Moesin and also 
resulted in similar tracheal phenotypes, i.e. multilumen defects. The multilumen phenotype 
probably results from the destabilisation of tubes resulting from depletion of the activated 
crosslinker p-Moesin, the function of which is regulated by Slik. To test this, I expressed the 
following functional variants of Slik in the tracheal system - Slik kinase dead (Slik
kd
) and 
Slik kinase domain (Slik
kin
) (Fig.33). Slik
kd
 is a slik mutant construct that lacks the kinase 
function as a consequence of a missense mutation in Asp
176
 residue within the kinase 
subdomain VII of the protein (HIPFNER and COHEN 2003). The Slik
kd
 mutation does not 
interfere with the protein’s ability to carry out its kinase independent function through the 
interaction with Raf (HIPFNER and COHEN 2003). On the other hand the Slik
kin
 construct 
retains only the kinase domain and lacks all other regions of the protein. Expression of the 
Slik
kin
 construct in wing disc has shown to increase levels of p-Moesin in cells (HIPFNER et 
al. 2004).  
  
Slik
kd
 overexpression in the larval tracheal system resulted in lethality during early larval 
stages and therfore only very few third instar larvae expressing the construct were obtained. 
Larvae from the overexpression experiment were dissected to examine the terminal cells. 
Overexpression of the Slik
kd
 construct resulted in terminal cells displaying the multilumen 
phenotype, similar to Slik/Moesin depletion (Fig.34a), suggesting that Slik’s kinase function 
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is responsible for the Slik depletion phenotype. A similar effect was observed with Slik
kin
 
overexpression, resulting in lethality with very few escapers. Examination of the terminal 
cells from Slik
kin
 overexpressing larvae revealed the occurrence of the multilumen phenotype 
(Fig.34b). On the other hand, expression of UAS-slik constructs did not result in any 
observable phenotypes in the tracheal system. 
 
 
 
Figure 33: Schematic representation of Slik variants used in the tracheal system 
Two variants constructs of Slik were used to study the effect of interfering with Slik kinase function. Wild type 
Slik protein is about 1300aa. The Slik kinase dead (Slik
kd
) construct is mutated in the kinase domain via 
substitution of the aspartate
176 
to asparagine and therefore is not capable of performing the phosphorylation 
function. The Slik kinase domain (Slik
kin
) construct lacks the entire C-terminus retaining only the kinase domain 
of the protein. 
 
 
 
Figure 34: Effect of overexpression of the kinase variants of Slik 
Terminal cells from third instar larvae visualised by tracheal specific cytoplasmic GFP (green) in (a) Slik
kd
 
overexpressing cell and; (b) Slik
kin
 overexpressing cell. Over expression of both the Slik variant constructs result 
in the same multilumen phenotype. Scale - 25 µm. 
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3.8 Breathless regulates expression of p-Moesin in the tracheal system 
 
To determine if the loss of p-Moesin seen in terminal cells was specific to slik RNAi, control 
knockdowns were also performed. I tested the expression of p-Moesin in knockdowns of 
other kinases expressed in the tracheal system. btl, raf and egfr were the kinases analysed by 
knockdowns. FGF signalling involving the ligand branchless (bnl) and the Receptor Tyrosine 
Kinase (RTK) breathless (btl) is indispensible for normal tracheal morphogenesis (GLAZER 
and SHILO 1991). Loss of btl expression or of any downstream signalling components such as 
Ras or raf perturbs tracheal development (LEE et al. 1996; REICHMAN-FRIED et al. 1994). 
Further, egfr is also involved in tracheal placode invagination and tracheal cell migration 
(CELA and LLIMARGAS 2006; LLIMARGAS and CASANOVA 1999). The results from the 
experiments are discussed below. 
 
3.8.1 p-Moesin levels are affected by breathless knockdown 
 
btl RNAi in the tracheal system was performed using the transgenic line VDRC 27106, a line 
with no potential off-target effect. The RNAi construct was expressed in the tracheal system 
using btlGal4 along with the expression of UAS-GFP and UAS-dicer. Knockdown of btl was 
performed at 25°C unlike other knockdowns performed at 29°C as larvae at higher 
temperatures were small in size and difficult to dissect. The larvae were filleted to reveal the 
tracheal system and stained using anti-Slik antibody. The phenotypes associated with the 
knockdown are described in section 3.9.1.  
 
Immunostaining for p-Moesin was done in btl RNAi larvae along with control larvae to check 
p-Moesin levels in terminal cells. Wild type larvae showed p-Moesin enriched at the apical 
membrane of terminal branches (Fig.35a). Surprisingly, the btl mutant larvae showed a 
complete loss of p-Moesin from the terminal cell branches (Fig.35c), similar to that observed 
in the case of slik knockdown (Fig.35b). To check if this phenotype was a result of the loss of 
signalling through the RTK-MAPK pathway, knockdown for raf was performed and analysed 
through immunostainings for p-Moesin.  
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Figure 35: Effect of knockdown of slik, btl and raf on p-Moesin in larval terminal cells  
Terminal cells from larvae of the genotypes (a-a'') wild type; (b-b'') slik RNAi; (c-c'') btl RNAi and (d-d'') raf 
RNAi, are visualised by tracheal specific cytoplasmic GFP (green) and antibodies specific for the 
phosphorylated form of Moesin (p-Moesin) (red). While the p-Moesin is clearly seen in surrounding tissues, 
levels of p-Moesin are reduced within the terminal cells upon slik (b') and btl (c') knockdown in comparison to 
wild type (a') and levels that remain unchanged in raf knockdown (d'). As p-Moesin is ubiquitously expressed, 
p-Moesin from underlying muscle tissue is also detected.  Scale - 25 µm. 
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raf knockdown was performed using the RNAi transgenic line VDRC 107766 which has no 
predicted off-targets. Crosses set at a higher temperature (29°C) resulted in larvae of small 
size and therefore difficult to dissect. RNAi was performed at 25°C as in the case of btl 
knockdown. Immunostaining for p-Moesin in the raf knockdown larvae did not show any 
changes in levels of p-Moesin (Fig.35d) suggesting that raf or the signalling pathway 
downstream of Btl is not involved in maintaining p-Moesin levels in terminal cells. Together, 
these results indicate that both slik and btl are critical for the p-Moesin levels in the terminal 
cell. There are no precedents implicating btl as an upstream activating kinase of Moesin.  In 
order to determine if the loss of p-Moesin was as result of transcriptional regulation of slik by 
btl, I performed immunostainings for Slik in btl knockdown larvae. 
 
3.8.2 breathless RNAi does not affect slik expression in terminal cells 
 
Staining for Slik in the tracheal system showed that Slik expression in terminal cells was not 
affected by btl knockdown (Fig.36). This result implied that Slik expression was not 
controlled by Btl and it was unlikely to be a transcriptional target of Btl signalling. However 
this does not exclude the possibility that Slik is post-translationally activated by Btl. 
Therefore I investigated if Moesin is a transcriptional or a post-translational target of the Btl 
signalling. 
 
 
Figure 36: Effect of btl RNAi on Slik levels in larval terminal cells 
Terminal cell from a btl knockdown third instar larva (a-a''). (a) Terminal cell is visualised by tracheal specific 
cytoplasmic GFP (green) and (a') anti-Slik antibody staining (red). Slik expression is undisturbed upon btl 
knockdown.  Slik expressed in surrounding tissues is also detected. Scale - 25 µm. 
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3.8.3 Moesin is a phosphorylation target specific to Breathless 
 
In order to ascertain whether the observed down regulation of p-Moesin in the btl RNAi 
terminal cells was a result of transcriptional or post-translational regulation, I carried out 
immunostainings for Moesin using a pan-Moesin antibody (F. Payre) in wild type and btl 
RNAi larvae. Staining for Moesin in wild type terminal cells showed that Moesin was 
distributed within the cytoplasm, with enrichment at the apical membrane (Fig.37a). In btl 
mutant terminal branches, Moesin distribution remained unchanged. This result indicated that 
Moesin expression was not under the transcriptional control of Btl. Together with the 
observation from p-Moesin immunostainings in btl mutants, these results support the idea 
that Moesin directly or indirectly (perhaps through Slik), is a post-translational target of Btl’s 
activity. This implies a novel role for btl in regulating the activity of Moesin through 
phosphorylation.  
 
 
Figure 37: Effect of btl RNAi on Moesin levels in larval terminal cells 
Terminal cells from larvae of the genotypes (a-a'') wild type; (b-b'') btl RNAi, visualised by tracheal specific 
cytoplasmic GFP (green) and antibodies specific for Moesin (red). Levels of Moesin remain unaltered in a btl 
knockdown terminal cell (a’ and b'), unlike levels of p-Moesin that is reduced upon btl knockdown. Moesin is 
expressed in all tissues therefore Moesin from surrounding tissues is also detected. Scale - 25 µm. 
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3.9 Knockdown of RTK/MAPK pathway components affect terminal cell 
branching  
 
The Bnl/Btl RTK pathway is essential for tracheal development in both embryonic and larval 
phases of development. The signalling from the RTK pathway is modulated through 
downstream effector molecules such as Ras/Raf and the MAPK. An important target of this 
Bnl/Btl MAPK signalling is the expression of the target gene srf. Srf is a transcription factor 
specifically expressed in the terminal cells. Loss of Srf results in loss of cytoplasmic 
outgrowth during terminal branching (AFFOLTER 1994; GUILLEMIN et al. 1996). It is also 
known that Slik apart from its kinase dependent function genetically and physically interacts 
with Raf and is consequently involved in the signalling mediated by Raf to promote cell 
growth and proliferation. However the growth and proliferative effect of Raf signalling has 
been shown to be independent of the MAPK pathway in wing imaginal discs (HIPFNER and 
COHEN 2003). In the tracheal system the RTK-MAPK signalling is active and we know that 
Slik is expressed and has a crucial role in normal tracheal development. The multilumen 
phenotype in slik RNAi can be attributed to the loss of activated Moesin, however these 
terminal cells also showed reduced branch growth. As raf functions to promote cell growth it 
would be interesting to know if the branching phenotype was a result of impaired Slik-Raf 
signalling in slik mutants. To study the possibility that in slik mutants the branching defects 
could be due to perturbed signalling via Raf, or as a consequence of disruption of the MAPK 
signalling pathway and the subsequent loss of Srf expression, I performed RNAi on the 
components of the pathway. RNAi was performed for the following genes, the two RTKs btl 
and egfr, the transducers Ras and raf and finally the terminal specific target, srf. I analysed 
the outcomes from various knockdowns and scored for branching phenotypes.  
 
3.9.1 Effect of breathless RNAi in the larval tracheal system 
 
btl RNAi knockdown was performed in terminal cells as previously described in chapter 
3.8.1 
. 
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3.9.1.1 Knockdown of breathless disrupts branching in terminal cells 
 
Apart from the regulation of p-Moesin described earlier, knockdown of btl produces tracheal 
defects. In btl RNAi terminal cells branching was severely compromised with no more than 
two branches per terminal cell (Fig.38). This is consistent with the branching phenotype seen 
in slik RNAi. The phenotype was observed in all terminal cells from the btl knockdown 
animals. 
 
 
Figure 38: Effect of btl RNAi on branching in terminal cells 
A terminal cell from a btl RNAi larva. Terminal cell were visualised by the tracheal specific expression of 
cytoplasmic GFP using btlGal4. Depletion of btl severely affects growth of terminal branches and the phenotype 
was 100% penetrant with no terminal cells having more two branches. Scale - 25 µm. 
 
 
3.9.1.2 breathless RNAi results in abnormal morphology of the cells of the 
dorsal trunk 
 
 In addition, I also examined the dorsal trunk in the mutant larvae. To visualise the cells of 
the dorsal trunk E-Cadherin (E-Cad) staining was performed. E-Cad localises to the 
membrane marking cell-cell junctions. In wild type, the dorsal trunk is composed of regular 
shaped cells that are intercalated, with the junctions between these cells having a smooth 
appearing (Fig.39a). In btl RNAi animals the staining showed distinct morphological changes 
in the cells of the dorsal trunk. The cells appeared to have lost their regular shape as 
visualised by the presence of irregular cell boundaries, as outlined by E-cad staining 
(Fig.39b).  
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Figure 39: Effect of btl RNAi on the dorsal trunk 
Dorsal trunk from larvae of the genotypes (a-a'') wild type; (b-b'') btl RNAi, visualised by tracheal specific 
cytoplasmic GFP (green) and antibodies specific for E-Cadherin (red). The cells that constitute the dorsal trunk 
in btl RNAi larvae showed abnormal morphology, the cell outlines were irregular in comparison to the wild type 
cells. E-Cad outlines the cell membrane as it is expressed at points of cell-cell contact (marked by arrow). Scale 
- 25 µm. 
 
3.9.2 Knockdown of Ras disrupts branching in terminal cells 
 
Ras is an important effector of FGF signalling. Ras transduces the signal from Btl to activate 
the MAPK signalling. Ras binds the serine/threonine kinase Raf and targets it to the 
membrane, which then leads to the activation of Raf, a step preceding MAPK induction in the 
tracheal system.  
 
Knockdown for Ras was performed using the line NIG 9375-2. This line has no potential off-
targets. Ras RNAi constructs were expressed along with UAS-GFP and UAS-dicer at 29°C. 
Expression of the Ras RNAi constructs in the tracheal system resulted in terminal cell 
branching defects similar to that of slik knockdown and btl knockdown discussed above. 
Branching in terminal cells was reduced compared to the wild type (Fig.40), albeit the 
phenotype was not as severe as with btl knockdown. Ras RNAi resulted in terminal cells with 
Results 
59 
 
branch counts ranging between 2 to 10 branches per cell. These results confirmed that 
tracheal branching morphogenesis was affected by knocking down components of the RTK-
MAPK signalling pathway. 
 
 
 
Figure 40: Effect of Ras RNAi in terminal cell branching 
A terminal cell from a Ras RNAi larva. Terminal cells were visualised by the tracheal specific expression of 
cytoplasmic GFP using btlGal4. Knockdown of Ras caused a moderate reduction in terminal branching. Scale - 
25 µm. 
 
3.9.3 Effect of raf RNAi on terminal cell development 
 
Knockdown for raf was performed as described in section 3.8.2.  
 
3.9.3.1 Knockdown of raf branching in terminal cells 
 
raf RNAi resulted in various tracheal defects. The most prominent phenotype was reduction 
in terminal cell branching as with other members of the RTK pathway, btl and Ras or slik.  
Knockdown of raf resulted in terminal branches with approximately 4-10 branches per cell 
(Fig.41). This phenotype was fully penetrant and therefore observed in all terminal cells of 
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the knockdown larvae. Also, the knockdown induced lethality at pupal stages. However, the 
branching phenotype observed was not as severe as observed with the btl knockdown. In 
addition, raf knockdown presented additional phenotypes which are described below. 
 
 
 
Figure 41: Tracheal specific raf RNAi reduces terminal branching in terminal cells 
Terminal cell from a raf knockdown third instar larva, expressing cytoplasmic GFP in the tracheal system. raf 
RNAi results in reduced branching in terminal cells. Scale - 25 µm 
 
3.9.3.2 Knockdown of raf results in cystic lumen within terminal cells 
 
In addition to the branching defects induced upon raf RNAi, the terminal cells showed 
another. Though not a completely penetrant phenotype, I observed the presence of cystic 
lumen within the terminal branches. The cystic lumen phenotype is best described as a 
bubble-like expansion of lumen at random intervals in the branch (Fig.42). The cystic lumen 
phenotype was observed as a sole phenotype or in combination with the reduced branching 
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phenotype or even the multilumen phenotype described in the next section. This is a distinct 
phenotype and previously unobserved in any knockdowns of the other members of RTK-
MAPK pathway.  
 
 
 
Figure 42: Tracheal specific raf RNAi in results cystic lumen within terminal cell 
Terminal cell from a raf knockdown third instar larvae were imaged. The larval trachea is visualised by the 
expression of cytoplasmic GFP by btlGal4. In addition to the branching phenotype the knockdown also resulted 
in luminal phenotypes, cystic lumen (marked by arrow) phenotype. Scale - 25 µm. 
 
3.9.3.3 Knockdown of raf results in multilumen phenotype in terminal cells 
 
A third phenotype commonly observed in the tracheal system of raf RNAi larvae was the 
multilumen phenotype. The terminal cells showed the occurrence of multiple tubes within a 
branch with or without additional phenotypes (Fig.43).  
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Figure 43: raf RNAi in terminal cells results in the multilumen phenotype 
The terminal cells were visualised by expression of cytoplasmic GFP using the btlGal4 driver. Upon raf RNAi 
terminal cells often resulted displayed in the multilumen phenotype (marked by arrows). Sometimes the 
multilumen phenotype was observed in combination with other phenotypes; here multilumen phenotype is 
present along with the cystic lumen phenotype (marked by arrow head). Scale - 25 µm. 
 
 
3.9.4 Knockdown of srf disrupts branching in terminal cells 
 
srf is a target of the FGF-MAPK signalling and a transcription factor that is critical in 
terminal cell development. srf mutants have abnormal terminal branching (GUILLEMIN et al. 
1996). In order to make a phenotypic comparison between slik and srf mutant phenotypes I 
performed srf RNAi in the tracheal system. Srf in the tracheal system was depleted using 
RNAi constructs for srf expressed using btlGal4 along with the expression of UAS-GFP and 
UAS-dicer constructs. The line used was VDRC 100609, which had no predicted off-targets 
and the RNAi was performed at 29°C. The knockdown resulted in animals with reduced body 
size. Third instar larvae from the knockdown experiment were dissected and imaged. 
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Analysis of the mutant larvae showed abnormal tracheal development. Branching was 
affected in almost all terminal cells of the knockdown larvae (Fig.44). The phenotype was 
similar to that observed with btl knockdown and any other members of the Btl/MAPK 
signalling pathway. The phenotype was also consistent with previously published data on srf 
mutants (AFFOLTER 1994; GUILLEMIN et al. 1996). In addition, the knockdown larvae did not 
progress to pupal stages. 
 
 
Figure 44: Effect of srf RNAi on terminal cell branching 
A terminal cell from a third instar larva upon srf knockdown, also expressing cytoplasmic GFP in the tracheal 
system. The knockdown resulted in severe reduction in terminal branching. Scale - 25 µm. 
 
 
3.9.5 Knockdown of egfr disrupts branching in terminal cells  
 
In addition to the RTK Btl, I also studied the effect of knockdown of the other functional 
RTK in the tracheal system; viz. egfr. Egfr plays an important role in tracheal placode 
invagination and migration of primary branches. To examine the role of EGFR in terminal 
cell development I performed egfr RNAi using the line VDRC 107130.  
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Knockdown of egfr resulted in a moderate reduction of branching in terminal cells (Fig.45).  
egfr knockdown animals entered pupal phases of development but did not eclose. The 
terminal cells showed a reduction in branch numbers but no other phenotypes were observed. 
 
 
Figure 45: Knockdown of egfr in the tracheal system affects terminal branching 
egfr knockdown was performed specifically in the tracheal system with RNAi constructs expressed using 
btlGal4. Also expressed in the trachea were UAS-dicer and UAS-GFP, the latter was used to help visualise the 
tracheal system. The RNAi resulted in a moderate reduction of terminal branch numbers. Scale - 25 µm. 
 
3.9.6 Evaluation of branching phenotype in mutants of RTK and 
downstream components 
 
As described in the previous sections, knockdowns for slik, Ras, raf, srf, btl and egfr all 
resulted in a branching phenotype. To evaluate and derive a phenotypic correlation between 
individual knockdowns for the branching phenotype I counted branches from terminal cells 
from each of the knockdowns. For this purpose, terminal branches from a specific subset of 
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terminal cells called the dorsal terminal cells were counted. Dorsal terminal cells are the two 
terminal cells found at the region of dorsal branch fusion (Fig.46). Branching points were 
counted in dorsal terminal cells from the tracheal segments tr3- tr5 (Fig.21a). These segments 
were identified by the presence of the tracheal stem cell cluster, the tracheoblasts (Fig.21b). 
A branching point was scored when the branch in question contained a lumen within and that 
the lumen was continuous with the lumen from the preceding branch (Fig.47). Cytoplasmic 
extensions from an existing branch bearing no lumen within were not scored for. Terminal 
cell branch count was performed on an average of 5-6 larvae, as often only 1-2 intact dorsal 
terminal cells from tr3-tr5 were obtained after dissection, partly due to the difficulty in 
dissection of small-sized animals resulting from knockdown.  
 
. 
Figure 46: Overview of the dorsal terminal cells in the third instar larva 
The tracheal system is visualised by the expression of cytoplasmic GFP in a tracheal specific manner using 
btlGal4. Visible here are the two dorsal trunks in a segment of the larva, from each of which arise a dorsal 
branch directed to the midline of the animal. The dorsal branches fuse with each other at the body midline and 
project two terminal cells beyond this fusion point. These terminal cells arising beyond the point of the fusion 
cells are called referred to as the dorsal terminal cells. Scale - 100 µm. 
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Figure 47: A terminal cell from a third instar wild type larva 
A branching point is considered so when the tube within the branch is connected to the tube from the preceding 
branch (yellow dots). Cytoplasmic extensions that do not contain a tube within are not considered as branching 
points (red dots). Scale - 25 µm. 
 
 
 
 
Figure 48: Number of branches in dorsal terminal cells from wild type and mutant larvae 
Number of branching points was counted for dorsal terminal cells in wild type, slik, btl, Ras, srf, and egfr 
knockdowns. To visualise terminal cells cytoplasmic GFP was expressed in the tracheal system using btlGal4, 
third instar larvae were filleted and the terminal cells were analysed. Numbers of branching points are plotted as 
dots; each dot represents the number of branching points for one cell, a total of 10 terminal cells were counted 
per genotype (n=10). The following were the average number of branches per cell along with their p-values 
from a Student’s t-test: wild type 17.95 ± 2.69, slik 6.3±4.76, p=2.72x 10-6, btl 1.1 ± 0.32, p= btl  1.75x10-14, Ras 
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4.3 ± 3.16, p= 5.1x10
-9
, raf  5.9 ± 2.51, p=5.5x10
-9
, srf  2 .7± 1.34, p= 4.35x10
-12
 and egfr 12.3 ± 2.11, p= 
6.25x10
-5
 
 
 
Branch counting was performed in the tracheal knockdowns for slik, btl, egfr, Ras, raf, srf 
along with wild type as control.  Branches from individual terminal cells were counted and 
plotted on a scatter plot. Branch counts form 10 dorsal terminal cells were analysed. Each dot 
on the scatter plot represents the number of branches in a single dorsal terminal cell (Fig.48). 
Branch counting in wild type terminal cells showed that average branch numbers in these 
cells were about 17.95 ± 2.69 (n=10). Branch counting from the knockdown animals showed 
that all knockdowns influenced terminal cells branch numbers but to different degrees 
(Fig.48, values in Appendix Fig.52). Branch counts revealed an overall reduction in the 
number of branches per cell. A Student’s t-test was also done to calculate the p-values for the 
branch numbers.  The p-values obtained were highly significant with all p values being p 
<0.001. These results confirmed that branching is indeed perturbed in knockdowns of slik, its 
interaction partner raf and members of the RTK-MAPK signalling and its target, srf.  
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4. DISCUSSION 
The Drosophila tracheal system is commonly used as a model to study the molecular and 
cellular basis of tube morphogenesis. Although several studies have focussed on 
understanding tracheal patterning and tube formation, the events that lead to the tracheal 
development in larval phases remain largely unexplored. Our interest in the tracheal system 
focuses on the development of the terminal cells, the cells that deliver oxygen to the target 
tissues. Of particular interest is the mechanism of terminal branch development and lumen 
formation. Very little is known about the molecular and cellular aspects of terminal cell 
development. Earlier studies in the larval tracheal system have shown that tube formation 
within terminal cells is ensued by tube stabilisation.  Only a handful of candidate genes have 
been identified with respect to fulfilling these functions. Tube stabilisation has been shown to 
require talin (rhea) and integrins (mew, if, mys) (LEVI et al. 2006), while the lumen formation 
requires the apical polarity complex Baz/Par6/aPKC, Crumbs, Btsz, Ikkε, Dlis-1 (Jayan N. 
Nair, PhD thesis) (GERVAIS and CASANOVA 2010; OSHIMA et al. 2006). It is understood that 
Moesin, by regulating actin organisation at the apical membrane, is essential for terminal 
branching and tube development (POLESELLO et al. 2002) (Jayan N. Nair, PhD thesis). While 
it is known that Moesin is essential for tube formation, it is not clear whether Moesin 
regulates the process of tube formation or whether it is required subsequent to tube formation 
in order to stabilise the newly formed tube. Moesin is a well characterised membrane anchor 
for the actin cytoskeleton and studies have shown that activation of Moesin through 
phosphorylation is a prerequisite for this function. Until recently, the kinase that activates 
Moesin was unknown, studies in wing imaginal discs identified Slik (a member of the Sterile-
20 kinase family) as the activation factor (HIPFNER and COHEN 2003; HIPFNER et al. 2004). 
This study demonstrates the functional relevance of Slik in the development and maintenance 
of the larval tracheal system. 
  
4.1 Persistent Slik expression in all stages of tracheal development 
 
Slik is known to regulate both Moesin and Merlin through phosphorylation leading to distinct 
effects. Phosphorylation activates Moesin, which then binds to F-actin and stabilises the actin 
cytoskeleton (POLESELLO et al. 2002). However, in case of Merlin, phosphorylation results in 
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the loss of its tumour suppressor function (HUGHES and FEHON 2006). In addition, Slik 
genetically and physically interacts with Raf in a kinase independent manner to promote 
growth and cell survival (HIPFNER and COHEN 2003). Previous works showed that both Slik 
and Moesin are enriched at the apical membrane of the wing disc epithelium and that the loss 
of Slik results in loss of p-Moesin (HIPFNER and COHEN 2003; HIPFNER et al. 2004).  
 
My experiments to investigate Slik expression and localisation in the tracheal system showed 
that that Slik is indeed expressed in the tracheal system. Slik showed enriched apical 
localisation from the very first stage of embryonic tracheal development, which then 
persisted through the entire embryonic tracheal development. Interestingly, the apical 
enrichment of Slik in the embryonic trachea is also mirrored by F-actin distribution in the 
tracheal cells (Appendix Fig.54) (LLIMARGAS and CASANOVA 1999). This suggests a possible 
role for Slik in regulating Moesin for actin stabilisation during the tracheal development. 
Stainings in larvae showed that Slik was also enriched at the apical membrane within 
terminal cells i.e. the membrane facing the tracheal lumen. Further, coimmunostainings for 
Slik and E-Cad in fusion cell of the dorsal trunk demonstrated that Slik localises more 
apically than the E-Cad labelled adherens junctions. These finding are consistent with the 
previously reported distribution pattern of Slik in the wing disc epithelium (HIPFNER et al. 
2004). Further, coimmunostainings for Slik and p-Moesin in the larval trachea showed that in 
addition to the enrichment of activated Moesin at the apical membrane, Moesin also 
colocalised with Slik in the terminal cells.  
 
4.2 Slik is important for tracheal development in Drosophila 
 
Earlier reports have implicated Slik in the proliferation and growth of cells in the wing 
imaginal disc through regulation of Moesin and Raf (HIPFNER and COHEN 2003; HIPFNER et 
al. 2004). Tracheal specific knockdown of slik disrupted the normal terminal cell 
development. The knockdown also resulted in reduced larval sizes along with perturbing 
further development from the larval stages. The reduced body size in larvae could be an 
indirect consequence of lowered metabolism due to lack of oxygenation. These results 
suggest that Slik’s function in the tracheal system is required not only for the terminal cell 
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development but also for the overall development in Drosophila. The observed phenotypes 
are consistent with slik
1
 mutants and MARCM clone phenotypes. However, unlike in wing 
discs where slik mutant cells undergo apoptosis slik RNAi does not reduced terminal cell 
numbers. Careful analysis revealed branching/growth and tube formation defects in slik 
compromised terminal cells. Further, immunostainings showed that loss of Slik leads to a 
complete loss of activated Moesin (p-Moesin) at the apical membrane of terminal cells. This 
is consistent with previously published data that Slik phosphorylates Moesin and specifically 
at the amino acid residue Threonine
556
.  
 
4.3 Moesin is essential for tube formation and stability in terminal cells 
 
In addition to the loss of p-Moesin, knockdown of slik also resulted in tube formation and 
branching defects within terminal cells. Most of the mutant cells showed a significant 
reduction in branching, as well as the multilumen phenotype. Moreover, the multilumen 
phenotype observed in slik mutant terminal cells is similar to the previously observed moesin 
knockdown phenotype (Jayan N. Nair, PhD thesis), indicating a possible link between the 
status of activated Moesin and the observed phenotypes. Since Slik has been shown to 
phosphorylate Moesin in other tissues (CARRENO et al. 2008; HIPFNER and COHEN 2003; 
HIPFNER et al. 2004; HUGHES et al. 2010), the similarity of the phenotypes between the loss 
of Moesin and Slik in the terminal cells, might be expected.  
 
Further evidence for the regulation and activation of Moesin at the apical membrane in 
terminal branches comes from studies in our lab. Terminal cells of bitesize (btsz) mutants as 
well as RNAi larvae showed tube formation and branching defects (unpublished data, Jayan 
N. Nair, Appendix Fig.50). btsz was previously identified as one of the membrane anchors of 
Moesin at the apical membrane in the embryonic epithelium (PILOT et al. 2006). 
Additionally, mutant alleles of talin, α-integrins and β -integrins also showed multiple 
lumens in terminal branches (Fig.6)(LEVI et al. 2006). The talin-integrin complex positioned 
at the basal membrane acts as an anchor for terminal branches to connect to the underlying 
tissues. This positioning is thought to occur through the interaction of the actin cytoskeleton 
with the talin-integrin complex leading to stabilisation of the tube in terminal branches. Since 
activated Moesin, which localises at the apical membrane in terminal branches, is an anchor 
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for F-actin it could stabilise the actin cytoskeleton at the apical membrane and thereby 
regulate terminal branching and tube formation.  
 
4.4 Kinase activity of Slik is essential for its function in terminal cells 
 
We know from earlier work that Slik’s kinase function is important for maintaining the 
epithelial integrity of wing imaginal discs (HIPFNER and COHEN 2003). Comparable terminal 
cell phenotypes in slik and moesin RNAi and the loss of p-Moesin enrichment at the apical 
membrane in slik mutants indicated that Slik’s kinase activity is essential for its function in 
terminal cells. To confirm this aspect, I tested the effects of expression of Slik variants in 
terminal cells. Overexpression of wild type Slik did not result in any phenotypes in the 
tracheal system. Overexpression of the kinase dead form of Slik (Slik
kd
) resulted in 
multilumen phenotype indicating that the kinase activity of Slik is indispensible in tracheal 
development. An explanation to this phenotype is that the Slik kinase dead construct acts as a 
dominant negative. The Slik
kd
 construct is a point mutation in the kinase subdomain of the 
protein and therefore the construct is likely to retain its kinase independent functions. This 
would allow other Slik interacting proteins to still associate with the kinase dead form. One 
such protein is Sip1 which is the Drosophila homologue of the mammalian EBP50/NHERF1. 
Sip1 is a scaffold protein which regulates several transmembrane receptors as well as 
downstream signal transduction
 
activity. Sip1 functions as a scaffold for Slik at the apical 
membrane (HUGHES et al. 2010). Slik
kd
 could still interact with Sip1 and occupy postions at 
membrane and at the same time bind to Moesin. However, despite the interaction Slik
kd
 
would be unable to phosphorylate Moesin and thus deplete pools of p-Moesin available to act 
as crosslinkers of F-actin to the apical membrane, leading to destabilised tubes and hence the 
multilumen phenotype. 
 
On the other hand, expression of Slik
kin
 has shown to increase levels of p-Moesin and cause 
relocalisation of p-Moesin from the apical surface (HIPFNER et al. 2004). Slik
kin 
has intact 
kinase domain but lacks the remaining domains, therefore cannot interact with Sip1 leading 
to loss of apical localisation. Unanchored Slik (Slik
kin
) perhaps activates Moesin at regions 
other than the apical membrane. Stabilisation of F-actin at random positions within the cells 
could lead to a disorganised cytoskeleton and thus the multilumen phenotype. This is 
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consistent with phenotype associated with overexpression of phosphomimetic form of 
Moesin in the tracheal system. Work from our lab showed that overexpression of Moesin
TD556 
(phosphomimetic form) in the trachea resulted in abnormal lumen phenotypes (Jayan N Nair, 
PhD thesis, Appendix Fig.52)  
 
Further evidence to support the idea that slik stabilises the cytoskeleton through Moesin can 
be obtained from slik
1 
mutant animals. Dorsal trunks of slik
1
 mutant larvae have smaller 
lumen when compared with wild type dorsal trunks of similar sizes. Lumen formation is 
determined by several factors, one of them is the arrangement of F-actin core at luminal site 
(OSHIMA et al. 2006). Also lumen expansion requires rearrangement of the actin 
cytoskeleton. Actin rearrangement and stabilisation requires the function of crosslinkers such 
as Moesin to anchor to the membrane. Loss of Slik in the dorsal branches affect levels of 
activated Moesin and this could lead to defects in actin organisation resulting in failure of 
lumen expansion. The severity of the phenotype is perhaps attenuated by the presence of the 
maternally expressed Slik which allows development of the trachea in escapers. To exclude 
the maternal contribution of Slik, analysis of the trachea from germline clone of slik
1 
have to 
be performed. 
 
To address the question if anchorage of Moesin to the membrane is a prerequisite to 
phosphorylation, further experiments have to be implemented. Mutations in two residues at 
the N-terminus of Moesin have been shown to inhibit binding to Phosphatidylinositol 4,5-
bisphosphate (PtdIns(4,5)P2) (ROCH et al. 2010). Experiments to rescue slik mutant 
phenotype with Moesin
TD556 
and Moesin
TD556
with additional PtdIns(4,5)P2 binding mutations 
should address the question
 
. 
 
4.5 FGF/RTK Breathless regulates Moesin in trachea 
 
Results from RNAi experiments demonstrated that in addition to Slik, Btl also contributes to 
the phosphorylation of Moesin. Stainings to detect pan-Moesin and Slik in the btl RNAi 
terminal cells showed levels of these remained unchanged. Further, knockdown of 
downstream signalling component of the Btl/MAPK pathway raf, did not affect levels of p-
Moesin in the terminal cells. These results imply that both Slik and Btl are equally important 
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for activation of Moesin. Further, my studies suggests that Btl mediated regulation of Moesin 
is at post-translational level and not at transcriptional level. p-Moesin staining in larvae of 
egfr knockdowns showed that distribution of p-Moesin was unaffected in the tracheal system 
(unpublished data Jayan N. Nair Appendix Fig.53). This confirmed that regulation of p-
Moesin was specific to just one of the RTKs expressed in the tracheal system, namely btl.  
 
It is clear from the results that activation of Moesin through phosphorylation at T
556
 in the 
tracheal system requires the function of both Btl and Slik. Btl mediated regulation of Moesin 
is a novel finding from this study. The contribution of Btl in the phosphorylation of Moesin 
may be either direct or indirect. The possibility that an RTK phosphorylates ERM protein is 
not unfounded. Substantial amount of evidence show that RTK phosphorylates ERM proteins 
directly or indirectly. First, Btl is a Receptor Tyrosine Kinases (RTK) with proven kinase 
activity (LEE et al. 1996). Direct phosphorylation of ERM proteins by RTK has been long 
established. Studies in mammalian systems have shown Ezrin the homologue of Moesin to 
the phosphorylated at N-terminal positions by EGFR (KRIEG and HUNTER 1992). Perhaps, Btl 
phosphorylates Moesin at N-terminal regions permitting subsequent phosphorylation by Slik 
at T
556
. A second possibility is that Slik itself needs to be activated to perform its kinase 
function in the trachea, the prerequisite being activation by Btl. Finally, recent work in 
mammalian cell culture systems showed that Nik (Nck interacting kinase/ Misshapen (Msn) 
in Drosophila), a Sterile 20 kinase induced phosphorylation of ERM proteins in response to 
EGF stimulation. Also, Moesin was shown to physically interact with Nik via its N-terminus 
and also to be directly phosphorylated at amino acid residue T
558
 by the NIK domain 
(BAUMGARTNER et al. 2006). It is probable the relation between Btl and Slik is similar to that 
described above for EGFR and NIK. Moreover, previous work has not biochemically proven 
that Slik directly phosphorylates Moesin (HIPFNER and COHEN 2003; HIPFNER et al. 2004) 
therefore one cannot exclude the possibility that one of the two kinase (Slik or Btl) activates 
an unknown protein that would phosphorylate the later allowing activation of Moesin. 
 
In order to determine how the two kinases Slik and Btl regulate and activate Moesin further 
studies are required. A kinase assay should reveal if Slik directly phosphorylates Moesin or 
whether it requires the coordinated action of Btl. It would also be interesting to know if Slik 
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is phosphorylated by Btl. Finally it would be important to look at p-Moesin level is an msn 
RNAi background to test if this also contributes to the activation of Moesin.  
 
 4.6 Possible function of Merlin in terminal cell development  
 
In addition to the regulating Moesin through its kinase activity Slik also regulates Merlin 
function, hence it is imperative to investigate the function of Merlin in tracheal development. 
The role of Merlin in tracheal development is unexplored. The large amounts of cytoplasmic 
material seen in terminal cells of Merlin knockdown animals can be attributed to the loss of 
the tumour suppressor function of Merlin. Loss of Merlin in mice have been to show to result 
in uncontrolled growth of tissues leading to enormous sized organs (YI and KISSIL 2010). 
Another possible factor contributing to size of terminal cells is the sustained expression of 
signalling molecules. Experiments in wing discs have showed Merlin to localise to both 
membrane and cytoplasmic compartment of the cell. The functional form of Merlin, i.e. the 
non-phosphorylated form showed a clear enrichment in the cytoplasm and often colocalised 
to endocytic compartments. Merlin and Expanded have been shown to regulate steady-state 
levels of signalling receptors (EGFR, Notch, Smoothened, and Patched) as well as adhesion 
molecules (E-cad, Fat). Loss of these proteins can cause hyperactivation of associated 
signalling pathways. In addition, Merlin;ex double mutant cells show that the receptor levels 
are upregulated at the plasma membrane as a result of defect in receptor clearance. Consistent 
with this, knockdown of Merlin would result in the failure of receptor endocytosis. EGFR is 
an important factor in tracheal development and also upregulates E-cad to maintain epithelial 
integrity of the migrating tracheal tubes. EGFR also promotes invagination of the tracheal 
placode (LLIMARGAS and CASANOVA 1999) as well primary branching (WAPPNER et al. 
1997). Perhaps sustained expression of some of these or other factors in the tracheal system 
results in the growth phenotype. Finally, as Merlin RNAi was not performed in combination 
with expanded, the activity of the functionally redundant protein/ interaction partner of 
Merlin cannot be disregarded unless a Mer/ex double knockdown is performed.  
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4.7 Does Slik modulate the MAPK pathway to regulate growth of terminal 
cells? 
 
Previous studies have shown that Slik-Raf mediated signalling in wing disc is independent of 
the canonical MAPK signalling and also independent of Silk’s kinase function. Slik-Raf 
interaction promotes cell proliferation and provides survival cues to cells of the wing disc 
epithelium (HIPFNER and COHEN 2003; HIPFNER et al. 2004). I wished to determine if the 
branching defect resulted from the loss of Moesin function or kinase independent Slik-Raf 
signalling events.  
 
However, raf is also an integral component of the Btl/MAPK signalling which is 
indispensable for tracheal development. Btl/MAPK signalling positively regulates expression 
of Srf, the transcription factor absolutely essential for terminal cell development. To test the 
hypothesis that Slik-Raf interaction modulated the Btl/MAPK pathway in the tracheal system, 
growth of terminal cells in Btl/MAPK and slik RNAi were compared by evaluating the 
number of branches in the knockdown terminal cells. Knockdown of members of the 
Btl/MAPK pathway and srf resulted in branching phenotypes. The phenotypes resulting from 
the knockdowns were comparable to those of slik RNAi larvae, with all knockdowns 
resulting in a significant reduction in branches. The results suggest a possible input into the 
Btl/MAPK signalling pathway via the Slik-Raf interaction, but these results still do not 
exclude the possibility that the Slik-Raf interaction may contribute to terminal branch 
development via a yet unknown pathway. 
 
To understand the dynamics of Slik-Raf interaction and its input into the Btl/MAPK 
signalling, further experiments are required. Since Slik and Raf interact genetically an 
epistatic experiment rescuing slik RNAi phenotype with Raf
gof
 should restore branching in 
terminal cells. An alternate assay would be to analyse if the phenotypes from Raf
gof
 is an 
attenuated by slik RNAi. A distinction between the Slik-Raf input into the Btl/MAPK and to 
the yet unknown pathway needs to be assessed through a few epistatic experiments such as 
rescue of slik branching phenotype by the expression of  rolled/erk, or srf. Additionally, 
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immunostaining for dpERK in trachea of slik knockdown larvae should reveal if slik 
contributes to Btl/MAPK signalling to promote terminal cell development.  
 
 
Figure 48: Schematic representation of the Silk’s role in terminal cell development 
Slik contributes to both tube and branch formation in terminal cells through two different pathways. Previous 
studies have showed that Slik regulates Moesin function by phosphorylation (P) (denoted by blue).  This works 
shows that both Breathless and Slik phosphorylate Moesin to activate it (denoted by green arrows). Activation 
of Moesin stabilises F-actin and in turn positions the tube within the terminal branch. The exact mechanism of 
how Breathless phosphorylates Moesin is yet unknown and could be achieved through any of the three 
mechanisms indicated (a) direct, (b) through regulation of slik and (c) through an unknown factor (denoted by 
red arrows). Slik’s input in to the Btl/MAPK signalling pathway is yet to be ascertained.  
 
From results so far, I can conclude that Slik is essential for normal tracheal development and 
in particular for tube formation and branching in the terminal cells (Fig.48). Further, my work 
shows that Moesin is a crucial effector downstream of Slik. In addition to Slik-mediated 
regulation of Moesin, this works shows that Btl is also involved in Moesin regulation. The 
mechanism by which Btl mediates regulation of Moesin is yet to be elucidated. Finally, in 
addition to tube formation, Slik may contribute to the branch formation in terminal cells 
through providing signalling input in to the Btl/MAPK pathway through the Slik-Raf 
interaction.  
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6. APPENDIX 
6.1 Terminal cell counts from tracheal segments tr3-5 from wild type and 
slik RNAi larvae 
  wt slik 
L1 32 32 
L2 25 29 
L3 29 34 
L4 31 34 
L5 29 27 
Avg. 29.2 31 
St.dev 2.68 3.082 
 
Figure 50: Terminal cell counts from wild type and slik RNAi  
 
L1-10 represents five different animals from which terminal cells were counted. Terminal 
cells were counted from the tracheal segments tr3-tr5 in both wild type and slik RNAi 
larvae. The average and standard deviation of both the data sets are shown in red 
 
6.2 Knockdown of btsz leads to lumen formation and branching defects in 
terminal cells 
 
 
Figure 51: btsz knockdown in terminal cell affect branching  
Terminal cells from btsz RNAi larva al cell were visualised by the tracheal specific expression of cytoplasmic 
GFP using btlGal4. Depletion of btl severely affects growth of terminal branches. Scale - 25µm 
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6.3 Branch counts from various knockdowns in the tracheal system 
 wt slik btl Ras raf srf egfr 
TC1 20 3 1 10 10 4 10 
TC2 16 6 1 7 8 3 17 
TC3 17 1 1 1 3 3 12 
TC4 17 2 1 1 3 2 11 
TC5 18 6 1 1 3 2 11 
TC6 21 2 2 3 7 1 13 
TC7 23 15 1 8 8 2 14 
TC8 16 6 1 4 4 1 10 
TC9 17 13 1 5 7 5 13 
TC10 14 9 1 3 6 4 12 
avg. 17.9 6.3 1.1 4.3 5.9 2.7 12.3 
st.dv 2.685351 4.762
119 
0.316228 3.16403
4 
2.514403 1.33749
4 
2.110819 
 
Fig 52: Branch counts in terminal cells upon RNAi of slik, btl, Ras, raf, srf, egr 
 
TC 1-10 represents 10 differenct terminal cells from which measurement was taken. The 
average and standard deviation of dboth the data sets are shown in red 
 
6.4 Overexpression of phosphomimetic form of Moesin in the tracheal 
system 
 
 
Figure 53: Overexpression of MoeTD
559
 (phosphomimetic form) in the terminal cells affect branching  
Terminal cells were visualised by the tracheal specific expression of  DS-Red along with the MoeTD
559
 using 
btlGal4. Depletion of btl severely affects growth of terminal branches and tube formation within the branches. 
Scale - 25µm 
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6.5 Knockdown of egfr does not affect p-Moesin localisation in terminal 
cells 
 
 
Figure 54: Effect of egfr knockdown on p-Moesin localisation in the terminal cell 
Terminal cell from a egfr knockdown third instar larva (a-a''). (a) Terminal cell is visualised by tracheal 
specific cytoplasmic GFP (green) and (a') p-Moesin (red). p-Moesin expression is undisturbed upon egfr 
knockdown.  p-Moesin expressed in surrounding tissues is also detected.  Scale - 25µm (Unpublished data, 
Jayan N.Nair ) 
 
6.6 Localisation of F-actin in developing embryonic tracheal system  
 
 
Figure 55: F-actin distribution in tracheal placodes of wild type stage 11 embryos 
Single confocal sections of embryos stained with anti-Vvl to visualise the tracheal cells (green) and incubated 
with phalloidin-Texas red to visualise actin distribution (red). Each image shows two metameres; anterior is to 
the left and dorsal is up. First panel shows a merged image of actin distribution and anti-Vvl to visualise the 
tracheal cells; the single image of the actin distribution is also shown in the next panel. A, B In wildtype 
embryos actin accumulates in the centre of the tracheal pit, outlining the point of invagination. (LLIMARGAS and 
CASANOVA 1999)  
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ABBREVIATIONS 
 
bp                  base pairs 
BSA Bovine Serum Albumen 
btl        breathless 
btsz           bitesize 
dNTP deoxy nucleotide tri phosphate 
dof Downstream of FGF 
egfr Epidermal growth factor receptor 
ERM              Ezrin-Radixin-Moesin  
ERK Extracellular-signal-Regulated Kinase (MAPK) 
FGF Fibroblast growth factor 
FLP  yeast Flp recombinase 
FRT               Flp recombinase target site 
GFP  Green fluorescent protein  
if  inflated 
Kb Kilo base 
M mol per litre 
m milli 
MAPK Mitogen Activated Protein Kinase 
MEK Mitogen-activated protein kinase/extracellular signal-regulated kinase kinase  
Mer          Merlin 
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mew multiple edematous wings 
moe moesin  
mys myospheroid 
 Micro 
ng               Nanogram 
PCR Polymerase Chain Reaction 
RTK  Receptor Tyrosine Kinase 
slik  SLK and LOK like kinase 
srf                  Serum response factor 
UAS  Upstream activating sequence 
VDRC  Vienna Drosophila Research Center
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ABSTRACT 
 
The Drosophila Sterile20 like kinase Slik is involved in maintaining epithelial integrity and 
promotes tissue growth during development. It regulates activity of members of the band 
4.1/Ezrin/Radixin/Moesin (ERM) superfamily proteins through phosphorylation. Apart from 
its kinase activity, Slik also interacts with Raf to promote cell survival and growth. Raf is an 
important downstream effector of the Bnl/Btl RTK pathway crucial for tracheal development. 
An immediate target of the RTK-MAPK signalling is SRF (serum response factor), a 
transcription factor known to be indispensible for terminal cell development. Here, I show 
that Slik contributes to tracheal terminal cell development through both its kinase-dependent 
and independent functions. Both Slik and activated Moesin (p-Moesin) are enriched at the 
apical membrane in terminal cells. slik mutant or knockdown terminal cells show branching 
defects and destabilised tubes similar to the phenotype of moesin mutants, suggesting that slik 
is an essential factor in terminal cell growth and development. This is further supported by 
the effect of expressing a kinase-dead form of slik, which causes a multilumen phenotype 
similar as the one seen in slik mutant cells. In addition, slik depletion results in the loss of p-
Moesin at the apical membrane in the terminal cells indicating that Slik through its kinase 
dependent function towards Moesin regulates tracheal terminal cell development. This study 
also reports a novel regulator of Moesin; I have identified Btl as an important factor that post-
translationally regulates the phosphorylation of Moesin.  
 
Apart from the luminal defects, slik depletion also resulted in reduced branching of terminal 
cells. The same phenotype is observed upon knockdown of raf. As Raf is thought not be a 
kinase substrate of Slik but rather a binding partner, the results suggest an additional, kinase 
independent function of Slik in tracheal development. The disruption of the downstream 
target of the Bnl/Btl signalling pathway srf, the signalling transducer Ras, or the receptor btl 
itself also resulted in similar branching defects. We propose that slik acts in the development 
of terminal cells through activation of Moesin at the apical membrane and a possible 
regulation of the Bnl/Btl RTK pathway through its interaction with Raf. 
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ZUSAMMENFASSUNG  
 
Die Drosophila Sterile 20 like kinase Slik ist sowohl am Erhalt der epithelialen Integrität als 
auch an der Förderung des Gewebewachstums während der Entwicklung beteiligt. Sie 
reguliert die Aktivität von Proteinen der Band 4.1/Ezrin/Radixin/Moesin (ERM) 
Proteinfamilie durch Phosphorylierung. Zusätzlich zur Kinaseaktivität interagiert Slik mit Raf 
und wirkt dadurch positiv auf die Überlebensrate und das Wachstum von Zellen ein. Raf ist 
ein wichtiger Faktor im Bnl/Btl RTK Signaltransduktionsweg, der unverzichtbar für die 
Tracheenentwicklung ist.  Ein direktes Zielgen des RTK-MAPK Signalwegs ist srf (serum 
response factor), ein Transkriptionsfaktor der für die Entwicklung der Terminalzellen 
unentbehrlich ist. In der vorliegenden Arbeit zeige ich, dass Slik auf zwei unterschiedlichen 
Wegen zur Tracheenentwicklung beiträgt; durch eine Kinase-abhängige als auch eine Kinase-
unabhängige Funktion. Sowohl Slik als auch aktiviertes Moesin (p-Moesin) liegen an der 
apikalen Membran der Terminalzelle angereichert vor. Terminalzellen, in denen die Funktion 
von slik entweder durch eine Mutation oder durch einen RNAi induzierten Knockdown 
gestört ist, zeigen Defekte in der Verästelung sowie eine Destabilisierung der intrazellulären 
Röhre. Dieser Phänotyp gleicht dem von moesin Mutanten und indiziert eine essentielle 
Funktion von slik im Wachstum und der Entwicklung der Terminalzellen. Der Effekt der 
Überexpression einer Kinase-defizienten Form von Slik unterstützt diese Annahme: es wird 
ein Multilumen-Phänotyp beobachtet, wie er auch in slik mutanten Zellen zu finden ist. 
Desweiteren  resultiert die Reduktion von Slik in einem Verlust von p-Moesin an der 
apikalen Membran in Terminalzellen. Dies deutet darauf hin, dass Slik durch seine Kinase-
Aktivität gegenüber Moesin die Entwicklung der trachealen Terminalzellen reguliert. In 
dieser Studie konnte ich überdies einen neuen Regulator von Moesin nachweisen: es zeigte 
sich, dass Btl die post-translationelle Phosphorylierung von Moesin reguliert.   
 
Zusätzlich zu den luminalen Defekten resultierte die Reduktion von Slik auch in einer 
geringeren Verästelung der Terminalzellen. Der Knockdown von Raf erzeugt denselben 
Phänotyp. Da Raf kein direktes Substrat der Slik Kinase zu sein scheint, sondern ein 
Interaktionspartner, legen diese Ergebnisse eine zweite, Kinase-unabhängige Funktion von 
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Slik in der Tracheenentwicklung nahe. Die Unterbrechung des Bnl/Btl 
Signaltransduktionsweges durch Knockdown des Zielgens srf, des Signalmoleküls ras oder 
des Rezeptors btl resultierte in ähnlichen Verästelungsdefekten.  Zusammenfassend 
postulieren wir folgendes Modell: Slik reguliert die Entwicklung der Terminalzellen durch 
die Aktivierung von Moesin an der apikalen Membran und beeinflusst den Bnl/Btl RTK 
Signaltransduktionsweg über die direkte Interaktion mit Raf.  
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